25 Protocols · 100% Generic INN

Reference Source:

Launch in App

ST-Elevation Myocardial Infarction (STEMI)

ICD-10: I21.0Source: Braunwald's Heart Disease - Ch. 58

History & Clinical Examination Pearls

  • •Key history points: Acute onset retrosternal crushing, squeezing chest pain or pressure lasting > 20 minutes, radiating to left arm, neck, jaw, epigastrium, or back
  • •Associated autonomic symptoms: Profuse cold diaphoresis, nausea, vomiting, acute dyspnea, overwhelming sense of impending doom
  • •Atypical presentations: Diabetics, elderly, and females frequently present with dyspnea alone ('anginal equivalent'), syncope, unexplained acute fatigue, nausea, or acute delirium without overt chest pain
  • •Hemodynamic status: Bradycardia (inferior STEMI vagal tone) or tachycardia, hypotension indicating pump failure/cardiogenic shock, hypertension due to sympathetic hyperactivity
  • •Killip Classification: Killip I (no rales/S3); Killip II (bibasilar rales < 50% lung fields, S3 gallop); Killip III (frank pulmonary edema > 50% lung fields); Killip IV (cardiogenic shock with SBP < 90 mmHg, oliguria, cold extremities)
  • •Right ventricular infarction signs: In inferior STEMI: Hypotension, clear lung fields, elevated jugular venous pressure (triad of RV infarction); verify with right-sided ECG leads V3R-V4R

Diagnostic Tests & Paraclinics

  • •Diagnostic 12-Lead ECG: New ST-segment elevation at the J-point in >= 2 contiguous leads: >= 1 mm in all leads except V2-V3; in V2-V3: >= 2.0 mm in men >= 40, >= 2.5 mm in men < 40, or >= 1.5 mm in women; or new Left Bundle Branch Block (LBBB) with Sgarbossa criteria
  • •Cardiac Biomarkers: High-sensitivity cardiac Troponin I or T markedly elevated (serial measurements, but do NOT delay catheterization laboratory activation for troponin results!)
  • •Echocardiography: Urgent bedside TTE demonstrating regional wall motion abnormality corresponding to the infarcted coronary vascular territory; assesses left ventricular ejection fraction and excludes mechanical rupture

Standard Inpatient Orders (100% Generic INN)

  • ✓Diet/Activity: Strict NPO, strict bed rest with continuous cardiac telemetry
  • ✓Monitoring: Continuous 12-lead ST-segment telemetry, automated BP monitoring every 5-10 minutes, pulse oximetry (supplemental O2 only if SpO2 < 90%)
  • ✓IV Hydration: 0.9% Normal Saline at keep-vein-open rate (30-50 mL/hr); avoid fluid overload unless right ventricular infarction is present
  • ✓Pharmacotherapy (Generic Only): Acetylsalicylic Acid (Aspirin) 300-325 mg non-enteric coated orally chewed immediately; PLUS P2Y12 Inhibitor loading: Ticagrelor 180 mg oral loading dose OR Clopidogrel 600 mg oral loading dose; Anticoagulation: Unfractionated Heparin 60 U/kg IV bolus (max 4000 U) followed by 12 U/kg/hr infusion (target aPTT 50-70s) OR Enoxaparin 30 mg IV bolus followed by 1 mg/kg subcutaneous every 12 hours; Nitroglycerin 0.4 mg sublingual every 5 minutes (max 3 doses) for chest pain, then continuous IV infusion 10-200 mcg/min (CONTRAINDICATED in RV infarction, SBP < 90 mmHg, or recent phosphodiesterase-5 inhibitor use within 24-48 hours!); Atorvastatin 80 mg orally daily; Metoprolol 25-50 mg orally every 12 hours once hemodynamically stable without heart failure; REPERFUSION: Urgent primary Percutaneous Coronary Intervention (PCI) with Door-to-Balloon time < 90 minutes; if transfer delay > 120 minutes, initiate Tenecteplase IV weight-adjusted bolus within 30 minutes

Red Flags & Clinical Pitfalls

  • !Cardiogenic shock (Killip IV): SBP < 90 mmHg, cardiac index < 2.2 L/min/m2, pulmonary capillary wedge pressure > 18 mmHg; requires emergent mechanical circulatory support and inotropes
  • !Mechanical complications (typically days 2-7): Ventricular septal rupture, acute severe mitral regurgitation due to papillary muscle rupture, or free wall rupture with tamponade; manifests as new harsh murmur and sudden collapse
  • !Malignant ventricular arrhythmias: Sustained Ventricular Tachycardia or Ventricular Fibrillation requiring immediate electrical defibrillation

Non-ST-Elevation Acute Coronary Syndrome (NSTEMI / UA)

ICD-10: I21.4Source: Braunwald's Heart Disease - Ch. 59

History & Clinical Examination Pearls

  • •Clinical presentations of Unstable Angina / NSTEMI: 1) Rest angina lasting > 20 minutes, 2) New-onset severe angina (CCS class III or IV within 2 months), 3) Crescendo angina (previously diagnosed angina that is distinctly more frequent, longer in duration, or lower in threshold)
  • •Risk factor burden: Diabetes mellitus, prior coronary artery bypass graft (CABG) or PCI, peripheral arterial disease, advanced age (> 65 years), chronic kidney disease
  • •TIMI and GRACE risk score calculations: Age >= 65, >= 3 CAD risk factors, known CAD (stenosis >= 50%), ASA use in past 7 days, severe angina in past 24h, elevated cardiac markers, ST deviation >= 0.5 mm
  • •Cardiovascular examination: Normal in many patients; examine for signs of hemodynamic compromise: diaphoresis, pale cool skin, hypotension, S3 or S4 gallop, new mitral regurgitation murmur (papillary muscle dysfunction)
  • •Pulmonary signs: Bilateral basilar crackles indicating left ventricular dysfunction and elevated left ventricular end-diastolic pressure
  • •Differential exclusion: Palpate chest wall (costochondritis), auscultate for pericardial friction rub (pericarditis), check bilateral arm blood pressure (aortic dissection)

Diagnostic Tests & Paraclinics

  • •12-Lead Electrocardiogram: Transient or persistent ST-segment depression >= 0.5 mm (0.05 mV), T-wave inversions >= 1 mm in contiguous leads with prominent R waves, or transient ST elevation; absence of persistent ST elevation
  • •High-Sensitivity Cardiac Troponin (hs-cTnI / hs-cTnT): Serial measurements at presentation and 1 or 2 hours (0/1-hour or 0/2-hour ESC accelerated diagnostic algorithm); dynamic rise and/or fall with at least one value above the 99th percentile URL confirms NSTEMI (troponin negative = Unstable Angina)
  • •Transthoracic Echocardiogram (TTE): Identifies transient or persistent regional wall motion abnormalities, left ventricular systolic ejection fraction, and excludes mechanical complications

Standard Inpatient Orders (100% Generic INN)

  • ✓Diet/Activity: Strict bed rest with continuous telemetry, NPO initially except water and oral medications
  • ✓Monitoring: Continuous 12-lead ST-segment monitoring, automated noninvasive blood pressure every 15-30 minutes, continuous pulse oximetry (supplemental O2 only if SpO2 < 90%)
  • ✓IV Hydration: 0.9% Normal Saline at keep-vein-open rate (30-50 mL/hr)
  • ✓Pharmacotherapy (Generic Only): DUAL ANTIPLATELET THERAPY: Acetylsalicylic Acid (Aspirin) 300 mg orally chewed loading dose, then 75-100 mg daily; PLUS Ticagrelor 180 mg oral loading dose, then 90 mg twice daily (or Clopidogrel 300-600 mg load if high bleeding risk); ANTICOAGULATION: Enoxaparin 1 mg/kg subcutaneously every 12 hours (adjust to 1 mg/kg every 24h if eGFR < 30 mL/min) OR Fondaparinux 2.5 mg subcutaneously daily OR Unfractionated Heparin 60 U/kg IV bolus (max 4000 U) followed by 12 U/kg/hr infusion (target aPTT 50-70s); ANTI-ISCHEMIC THERAPY: Nitroglycerin 0.4 mg sublingually every 5 minutes (up to 3 doses), then IV infusion 10-200 mcg/min for ongoing ischemic chest discomfort; Metoprolol 25-50 mg orally every 12 hours (target resting HR 55-60 bpm; avoid in acute heart failure or cardiogenic shock risk); HIGH-INTENSITY STATIN: Atorvastatin 80 mg orally daily; INVASIVE STRATEGY: Urgent coronary angiography < 2 hours for refractory angina, hemodynamic instability, or VT; early invasive < 24 hours for high GRACE score

Red Flags & Clinical Pitfalls

  • !Refractory or recurrent ischemic chest pain despite maximal medical therapy indicating impending transmural infarction
  • !Development of acute heart failure (Killip Class III) or cardiogenic shock requiring emergent coronary angiography
  • !New onset sustained Ventricular Tachycardia or Ventricular Fibrillation

Acute Decompensated Heart Failure (ADHF)

ICD-10: I50.9Source: Braunwald's Heart Disease - Ch. 47

History & Clinical Examination Pearls

  • •Key history points: Rapidly worsening dyspnea on exertion, orthopnea (requiring multiple pillows), paroxysmal nocturnal dyspnea (waking up gasping for air), progressive bilateral leg swelling
  • •Precipitating factors: Dietary sodium or fluid indiscretion, medication non-adherence, acute coronary ischemia, uncontrolled severe hypertension, acute arrhythmias (atrial fibrillation), systemic infection, NSAID use
  • •Hemodynamic profile triage: Forrester hemodynamic subsets: Warm-Wet (most common: congested and well perfused), Cold-Wet (congested and hypoperfused - cardiogenic shock), Cold-Dry (hypovolemic), Warm-Dry (compensated)
  • •Congestion markers: Elevated jugular venous distension (> 8 cm H2O), positive hepatojugular reflux, bilateral pulmonary crackles/rales, third heart sound (S3 gallop), hepatomegaly, bilateral 3+ to 4+ pitting pretibial/sacral edema
  • •Perfusion markers: Narrow pulse pressure, cool clammy extremities, delayed capillary refill, resting diaphoresis, altered sensorium
  • •Vital signs: Tachypnea (RR > 28 bpm), resting tachycardia, hypertension (vascular failure) or hypotension (myocardial failure)

Diagnostic Tests & Paraclinics

  • •Natriuretic Peptides: B-type Natriuretic Peptide (BNP > 400 pg/mL) or NT-proBNP (> 900 pg/mL in age 50-75, > 1800 pg/mL in age > 75) confirms cardiac congestion with high sensitivity
  • •Chest Radiography: Cardiomegaly (cardiothoracic ratio > 0.5), cephalization of pulmonary vessels, Kerley B lines, interstitial/alveolar pulmonary edema, bilateral pleural effusions
  • •Echocardiography: Left ventricular ejection fraction (HFrEF vs HFpEF), regional wall motion abnormalities, severe valvular pathology, elevated estimated pulmonary artery systolic pressure

Standard Inpatient Orders (100% Generic INN)

  • ✓Diet/Activity: Strict low sodium diet (< 2 g/day), strict fluid restriction (< 1.5 L/day), upright sitting position with legs dangling over bedside to reduce preload
  • ✓Monitoring: Continuous pulse oximetry, cardiac telemetry, noninvasive ventilation support (CPAP 5-10 cmH2O or BiPAP 10/5 cmH2O for acute pulmonary edema), strict daily morning weights, hourly Foley urine output
  • ✓IV Hydration: Strict fluid restriction; no maintenance IV fluids!
  • ✓Pharmacotherapy (Generic Only): FIRST-LINE DIURETIC: Furosemide IV bolus at 2 to 2.5 times the patient's home oral daily dose (e.g., 80-160 mg IV) over 10 minutes (target net negative fluid balance 1.5-2.0 liters in 24 hours); if diuretic resistant: add Metolazone 5 mg orally 30 minutes prior to IV loop diuretic; VASODILATOR (if SBP > 110 mmHg and Warm-Wet): Nitroglycerin continuous IV infusion starting at 20 mcg/min titrated up to 200 mcg/min to rapidly relieve preload and afterload; INOTROPE (if Cold-Wet with SBP < 90 mmHg / cardiogenic shock): Dobutamine continuous IV infusion at 2.5-10 mcg/kg/min or Milrinone 0.25-0.75 mcg/kg/min; continue or optimize guideline-directed medical therapy once stabilized

Red Flags & Clinical Pitfalls

  • !Flash pulmonary edema with acute hypoxemic respiratory failure (PaO2/FiO2 < 200) requiring urgent noninvasive or invasive mechanical ventilation
  • !Cardiorenal syndrome type 1: Worsening serum creatinine (> 0.5 mg/dL rise) with worsening oliguria despite aggressive diuretic therapy
  • !Cardiogenic shock with systolic BP < 85 mmHg and end-organ hypoperfusion requiring inotropic support and mechanical circulatory assistance

Acute Atrial Fibrillation with Rapid Ventricular Response (RVR)

ICD-10: I48.0Source: Braunwald's Heart Disease - Ch. 38

History & Clinical Examination Pearls

  • •Key history points: Sudden onset palpitations, racing heart, fluttering sensation in chest, shortness of breath, lightheadedness, fatigue, angina pectoris
  • •Episode duration: Precise onset time (< 48 hours vs >= 48 hours or unknown duration; critical for thromboembolism risk stratification before chemical or electrical cardioversion)
  • •Secondary triggers: Acute infection, fever, thyrotoxicosis, alcohol binge ('holiday heart syndrome'), pulmonary embolism, acute myocardial infarction, electrolyte derangements, hypoxemia
  • •Pulse characteristics: Irregularly irregular pulse rhythm with variable volume; pulse deficit (apical heart rate higher than peripheral radial pulse rate)
  • •Hemodynamic instability assessment: Presence of sustained hypotension (SBP < 90 mmHg), acute pulmonary edema, acute ischemic chest pain, or altered mental status
  • •Cardiovascular signs: Variable intensity of first heart sound (S1), absence of 'a' wave in jugular venous pulse pulsations

Diagnostic Tests & Paraclinics

  • •12-Lead ECG: Absence of distinct P waves, replaced by fibrillatory 'f' waves (rate 350-600 bpm), irregularly irregular R-R intervals, ventricular response rate typically 120-180 bpm
  • •Laboratory investigations: Thyroid stimulating hormone (TSH) and free T4, serum electrolytes (potassium, magnesium), cardiac troponin, complete blood count
  • •Echocardiography: Transthoracic echocardiogram to assess left atrial enlargement, left ventricular systolic function, valvular disease; Transesophageal echocardiogram (TEE) to exclude left atrial appendage thrombus prior to cardioversion if AF >= 48 hours

Standard Inpatient Orders (100% Generic INN)

  • ✓Diet/Activity: NPO until rate stabilized, bed rest with continuous cardiac telemetry
  • ✓Monitoring: Continuous 12-lead ECG telemetry, noninvasive blood pressure every 15 minutes, continuous pulse oximetry
  • ✓IV Hydration: 0.9% Normal Saline at 50-75 mL/hr maintenance; avoid fluid overload
  • ✓Pharmacotherapy (Generic Only): IF HEMODYNAMICALLY UNSTABLE: Immediate Synchronized Direct Current Cardioversion (DCCV) starting at 120-200 J biphasic under IV sedation; IF HEMODYNAMICALLY STABLE: Rate Control: Metoprolol 2.5-5.0 mg IV bolus over 2 minutes, repeated every 5 minutes up to 3 doses (total 15 mg) OR Diltiazem 0.25 mg/kg IV bolus (approx 15-20 mg) over 2 minutes, followed by 5-15 mg/hr continuous infusion (CONTRAINDICATED in decompensated HFrEF); if HFrEF present: Digoxin 0.25-0.5 mg IV slow bolus OR Amiodarone 150 mg IV over 10 minutes followed by 1 mg/min for 6 hours; ANTICOAGULATION: Calculate CHA2DS2-VASc score; initiate anticoagulation with Heparin IV infusion or Enoxaparin 1 mg/kg SC or Direct Oral Anticoagulant (Apixaban 5 mg twice daily or Rivaroxaban 20 mg daily)

Red Flags & Clinical Pitfalls

  • !Wolff-Parkinson-White (WPW) syndrome with pre-excited AF: Wide, bizarre, irregular QRS tachycardia; AV nodal blockers (adenosine, beta-blockers, diltiazem, verapamil, digoxin) are STRICTLY CONTRAINDICATED as they accelerate conduction down accessory pathway causing VF! Treat with Procainamide or DCCV
  • !Acute pulmonary edema or severe angina in the setting of ventricular rate > 160 bpm requiring emergent cardioversion
  • !Cardioversion in AF duration > 48 hours without therapeutic anticoagulation or TEE, precipitating acute embolic stroke

Acute Aortic Dissection (Stanford Type A & Type B)

ICD-10: I71.00Source: Braunwald's Heart Disease - Ch. 40

History & Clinical Examination Pearls

  • •Classic symptom characteristics: Sudden, abrupt onset of excruciating, sharp, 'tearing', 'ripping', or 'knife-like' pain that reaches peak intensity instantaneously at onset
  • •Pain localization and migration: Anterior chest pain (suggests ascending aorta - Stanford Type A); interscapular back pain or abdominal pain (suggests descending aorta - Stanford Type B); migratory pain following the anatomical path of dissection propagation
  • •Predisposing risk factors: Chronic long-standing hypertension (70-80%), bicuspid aortic valve, Marfan syndrome, Loeys-Dietz syndrome, vascular Ehlers-Danlos syndrome, aortic coarctation, prior cardiac surgery, intense weightlifting, cocaine abuse
  • •Pulse deficits & Blood pressure asymmetry: Significant difference (> 20 mmHg systolic) in blood pressure between arms, or diminished/absent radial, femoral, or pedal pulses
  • •Aortic valve auscultation: New early diastolic decrescendo blowing murmur of aortic regurgitation at the right sternal border (present in 40-50% of Type A dissections)
  • •Neurological deficits: Focal neurological symptoms (stroke, hemiparesis, Horner syndrome from sympathetic chain compression, hoarseness from recurrent laryngeal nerve compression, paraplegia from spinal cord ischemia)

Diagnostic Tests & Paraclinics

  • •CT Angiography (Aorta Protocol): Gold standard diagnostic imaging modality (sensitivity and specificity > 98%): demonstrates the intimal intraluminal flap separating the true lumen from the false lumen, entry tear location, branch vessel involvement, and pericardial/pleural hematoma
  • •Transthoracic & Transesophageal Echocardiography: Bedside TTE/TEE in hemodynamically unstable patients: identifies ascending aortic flap, severe aortic regurgitation, and pericardial effusion/cardiac tamponade
  • •Electrocardiogram & Chest X-Ray: 12-lead ECG is normal in 30% or shows LVH (inferior ST-elevation occurs if dissection flap shears the right coronary artery ostium!); CXR shows widened superior mediastinum (> 8 cm) and abnormal aortic contour

Standard Inpatient Orders (100% Generic INN)

  • ✓Diet/Activity: Strict NPO, strict bed rest with continuous cardiac telemetry, quiet environment
  • ✓Monitoring: Arterial line blood pressure monitoring in the arm with the higher blood pressure, continuous ECG telemetry, Foley catheter for strict hourly urine output
  • ✓IV Hydration: Fluid restriction unless hypotensive; keep vein open with 0.9% Normal Saline
  • ✓Pharmacotherapy (Generic Only): FIRST-LINE BETA-BLOCKADE (Mandatory before vasodilators to prevent reflex tachycardia and increased shearing forces!): Esmolol IV loading dose 500 mcg/kg over 1 minute followed by continuous infusion at 50-200 mcg/kg/min OR Labetalol 20 mg IV bolus over 2 minutes, followed by 20-80 mg every 10 minutes (max 300 mg) or continuous infusion at 0.5-2.0 mg/min (target HR strictly < 60 bpm); SECOND-LINE VASODILATOR (Add ONLY after heart rate is strictly < 60 bpm): Nicardipine 5-15 mg/hr IV infusion OR Sodium Nitroprusside 0.5-5.0 mcg/kg/min IV infusion (target SBP strictly 100-120 mmHg); ANALGESIA: Morphine 2-4 mg IV or Fentanyl 50-100 mcg IV titrated for severe pain (essential to blunt sympathetic surge); SURGICAL INTERVENTION: Stanford Type A: Emergent open surgical repair; Stanford Type B: Medical ICU therapy or TEVAR if complicated

Red Flags & Clinical Pitfalls

  • !Administering pure vasodilators (nitroprusside, hydralazine) without prior beta-blockade, precipitating reflex tachycardia, increased dP/dt, and fatal aortic rupture
  • !Cardiac tamponade due to retrograde dissection into pericardial sac (hypotension, distended neck veins, muffled heart sounds; EMERGENCY: DO NOT perform routine pericardiocentesis as it can cause sudden hemodynamic collapse; immediate open surgical repair!)
  • !Malperfusion syndrome: Acute mesenteric ischemia, renal failure, or limb ischemia due to true lumen compression

Cardiogenic Shock Secondary to Acute Left Ventricular Failure

ICD-10: R57.0Source: Braunwald's Heart Disease - Ch. 60

History & Clinical Examination Pearls

  • •Etiological triggers: Extensive acute myocardial infarction (> 40% LV loss), acute decompensated end-stage cardiomyopathy, acute fulminant myocarditis, or mechanical complications of MI (VSR, papillary rupture)
  • •Clinical symptom onset: Rapid progression of dyspnea at rest, chest discomfort, profound weakness, confusion, cold clammy extremities, and marked oliguria
  • •Prior cardiovascular history: Prior myocardial infarction, known low baseline ejection fraction, multi-vessel coronary artery disease, or recent chest trauma
  • •Hemodynamic profile: Severe persistent hypotension (systolic BP < 90 mmHg for > 30 minutes or requiring vasopressors) with narrow pulse pressure, marked resting sinus tachycardia (or severe bradycardia)
  • •Peripheral hypoperfusion markers: Cold, clammy, mottled extremities, prolonged capillary refill time (> 3 seconds), altered mental status (confusion, somnolence), and diaphoresis
  • •Cardiac and pulmonary auscultation: Elevated jugular venous pressure, bilateral diffuse pulmonary rales/crackles, prominent S3 gallop, soft S1, new holosystolic murmur if papillary rupture or VSR

Diagnostic Tests & Paraclinics

  • •Biomarkers & Arterial Blood Gas: Marked lactic acidosis (arterial lactate > 2.0-4.0 mmol/L), severe mixed metabolic and respiratory acidosis, marked elevation of cardiac troponin and natriuretic peptides (BNP/NT-proBNP)
  • •Hemodynamic catheterization (Pulmonary Artery Catheter): Depressed cardiac index (< 2.2 L/min/m2 without support, < 1.8 L/min/m2 with support), elevated pulmonary capillary wedge pressure (PCWP > 15-18 mmHg), elevated systemic vascular resistance (SVR > 1400 dynes.sec.cm-5)
  • •Echocardiography: Severely depressed left ventricular ejection fraction (< 20-30%), severe diffuse or regional wall motion hypokinesis/akinesis, dilated LV, evaluation for mechanical complications (VSR, acute MR, tamponade)

Standard Inpatient Orders (100% Generic INN)

  • ✓Diet/Activity: Strict NPO, intensive care unit admission with head of bed elevated 30 degrees if blood pressure permits, immediate endotracheal intubation for respiratory exhaustion
  • ✓Monitoring: Continuous invasive arterial line, pulmonary artery catheter or noninvasive continuous cardiac output monitoring, central venous pressure, Foley catheter with urometer for hourly urine output (target > 0.5 mL/kg/hr)
  • ✓IV Hydration: STRICT FLUID RESTRICTION; cautious 250 mL crystalloid challenge ONLY if PCWP is documented to be low/normal (< 15 mmHg)
  • ✓Pharmacotherapy (Generic Only): VASOPRESSOR OF CHOICE: Norepinephrine continuous IV infusion starting at 0.05-0.1 mcg/kg/min (titrated to maintain MAP >= 65 mmHg); INOTROPIC SUPPORT: Dobutamine continuous IV infusion at 2.5-10 mcg/kg/min (or Milrinone 0.25-0.5 mcg/kg/min if SVR is excessively high, avoiding boluses); add Vasopressin at 0.03 units/min for refractory vasoplegic shock; MECHANICAL CIRCULATORY SUPPORT: Early placement of Intra-Aortic Balloon Pump (IABP), percutaneous ventricular assist device (Impella), or veno-arterial Extracorporeal Membrane Oxygenation (VA-ECMO); REPERFUSION: Immediate emergency coronary angiography with primary PCI or emergent surgical CABG if ischemic etiology

Red Flags & Clinical Pitfalls

  • !Refractory lactic acidosis (> 4 mmol/L) and anuria despite maximal dual vasopressor/inotrope support indicating impending multi-organ failure (prompt consideration for VA-ECMO or Impella)
  • !Sudden acute hemodynamic collapse with new loud harsh murmur (suspect acute ventricular septal rupture or complete papillary muscle rupture requiring emergent open surgical repair)
  • !Using pure beta-agonists or high-dose dopamine without norepinephrine causing lethal tachyarrhythmias and excessive myocardial oxygen consumption

Acute Medical Cardiac Tamponade

ICD-10: I31.4Source: Braunwald's Heart Disease - Ch. 83

History & Clinical Examination Pearls

  • •Underlying predisposing etiologies: Malignancy (lung, breast, lymphoma), viral or idiopathic pericarditis, uremia (end-stage renal disease), systemic autoimmune disease (SLE), tuberculosis, post-myocardial infarction (Dressler syndrome), recent pacemaker/ablation procedure
  • •Symptom presentation: Acute or subacute progressive dyspnea, orthopnea, chest fullness or dull retrosternal ache, extreme fatigue, presyncope or frank syncope
  • •Rapidity of accumulation: Small volumes (150-250 mL) accumulating rapidly can produce fatal tamponade due to steep pericardial stiffness curve, whereas slow accumulation allows parietal pericardial stretching up to 1-2 liters
  • •Beck's Classic Diagnostic Triad: 1) Systemic arterial hypotension, 2) Elevated jugular venous pressure with distended neck veins (absent 'y' descent), 3) Muffled, distant heart sounds
  • •Pulsus Paradoxus: An inspiratory decline in systolic blood pressure greater than 10 mmHg during normal quiet breathing (measured by manual sphygmomanometer)
  • •Perfusion and autonomic signs: Sinus tachycardia (compensatory mechanism to preserve cardiac output), cold clammy extremities, peripheral cyanosis, tachypnea without pulmonary crackles (lungs are typically clear!)

Diagnostic Tests & Paraclinics

  • •Echocardiography (Definitive Bedside Modality): Moderate-to-large pericardial effusion; early diastolic collapse of the right ventricle (high specificity); late diastolic collapse of the right atrium (high sensitivity); dilated, plethoric inferior vena cava (IVC) with < 50% inspiratory collapse; exaggerated respiratory variation (> 25-40%) in mitral and tricuspid inflow Doppler velocities
  • •12-Lead Electrocardiogram: Sinus tachycardia; low QRS voltage in all limb and precordial leads; Electrical Alternans (beat-to-beat variation in QRS amplitude and axis caused by swinging of the heart in the fluid-filled pericardium)
  • •Chest Radiography: Symmetrically enlarged 'water-bottle' cardiac silhouette with clear lung fields (absence of pulmonary venous congestion differentiates from heart failure)

Standard Inpatient Orders (100% Generic INN)

  • ✓Diet/Activity: Strict NPO, bed rest with patient positioned supine or head slightly elevated; NEVER sit upright if severely hypotensive
  • ✓Monitoring: Continuous ECG telemetry, automated BP monitoring every 3-5 minutes, bedside ultrasound available at bedside, continuous arterial line monitoring
  • ✓IV Hydration: 0.9% Normal Saline 500-1000 mL IV bolus rapidly over 20-30 minutes to increase right ventricular filling pressure and temporarily restore cardiac output pending drainage
  • ✓Pharmacotherapy (Generic Only): DEFINITIVE EMERGENCY PROCEDURE: Urgent ultrasound-guided or fluoroscopy-guided percutaneous Pericardiocentesis with indwelling pigtail catheter placement; surgical pericardial window if effusion is loculated, purulent, or recurrent; INOTROPIC/VASOPRESSOR BRIDGE: Norepinephrine continuous IV infusion 0.05-0.2 mcg/kg/min or Dobutamine 2.5-10 mcg/kg/min as a temporary hemodynamic bridge; AVOID VASODILATORS AND DIURETICS: Furosemide, nitrates, and ACE inhibitors are STRICTLY CONTRAINDICATED (preload reduction causes immediate cardiac arrest); AVOID POSITIVE PRESSURE VENTILATION: Positive intrathoracic pressure severely impedes venous return and can trigger instantaneous PEA arrest

Red Flags & Clinical Pitfalls

  • !Administering diuretics (e.g., Furosemide) or vasodilators (precipitates catastrophic irreversible hemodynamic collapse and death)
  • !Elective endotracheal intubation with positive pressure ventilation before relieving pericardial pressure (positive intrathoracic pressure abolishes venous return causing immediate PEA arrest)
  • !Electrical alternans on ECG indicating massive swinging heart with impending catastrophic circulatory arrest

Sustained Monomorphic Ventricular Tachycardia

ICD-10: I47.2Source: Braunwald's Heart Disease - Ch. 39

History & Clinical Examination Pearls

  • •Clinical presentation: Sudden onset rapid palpitations, lightheadedness, presyncope, frank syncope, acute chest tightness, or severe shortness of breath
  • •Underlying substrate: Prior myocardial infarction with myocardial scar (reentry circuit), ischemic or dilated cardiomyopathy, prior cardiac surgery, arrhythmogenic right ventricular cardiomyopathy (ARVC), or cardiac sarcoidosis
  • •Definition: Regular wide-complex tachycardia originating below the bundle of His with duration > 30 seconds or causing immediate hemodynamic collapse
  • •Hemodynamic stability stratification: Immediate assessment for shock: severe hypotension (SBP < 90 mmHg), acute pulmonary edema, altered mental status, or ischemic chest pain
  • •Atrioventricular dissociation signs on physical exam: Irregular, prominent cannon 'a' waves in the jugular venous pulse (atria contracting against closed tricuspid valve), variable intensity of the first heart sound (S1), beat-to-beat variation in systolic blood pressure
  • •Cardiovascular signs: Tachycardia usually regular at 140-220 bpm, diaphoresis, pallor, cool extremities

Diagnostic Tests & Paraclinics

  • •12-Lead ECG Analysis (Brugada & Vereckei Criteria): Wide QRS complex (duration > 140 ms in RBBB-like, > 160 ms in LBBB-like); AV dissociation (independent P waves, fusion beats, capture beats); concordance of QRS polarity across precordial leads (all positive or all negative V1-V6); initial R wave in lead aVR; extreme axis deviation ('northwest axis' -90° to 180°)
  • •Electrolyte and Metabolic panel: Urgent serum potassium, magnesium, calcium, blood gas, and cardiac troponin to identify reversible ischemic or metabolic triggers
  • •Urgent Bedside Echocardiography: Assess LV systolic function, regional wall motion abnormalities, myocardial scar, aneurysm, or mechanical complications

Standard Inpatient Orders (100% Generic INN)

  • ✓Diet/Activity: Strict NPO, immediate bed rest with continuous defibrillator pads attached to patient
  • ✓Monitoring: Continuous 12-lead ECG telemetry, continuous arterial line or automated blood pressure every 2-3 minutes, pulse oximetry, capnography
  • ✓IV Hydration: 0.9% Normal Saline at 50 mL/hr KVO; correct any hypovolemia
  • ✓Pharmacotherapy (Generic Only): IF UNSTABLE (Hypotension, pulmonary edema, angina, altered consciousness): Immediate Synchronized Direct Current Cardioversion (DCCV) at 100-200 J biphasic under brief IV procedural sedation (Etomidate 0.1-0.2 mg/kg or Midazolam 2-4 mg); IF STABLE: FIRST-LINE ANTIARRHYTHMIC: Amiodarone 150 mg IV infused over 10 minutes, followed by 1 mg/min IV infusion for 6 hours, then 0.5 mg/min for 18 hours (max 2.2 g in 24 hours) OR Procainamide 20-50 mg/min IV infusion (up to 17 mg/kg total load) until arrhythmia suppressed, hypotension ensues, or QRS widens > 50%; ELECTROLYTE OPTIMIZATION: Maintain serum potassium > 4.5 mEq/L and serum magnesium > 2.0-2.5 mg/dL (administer Magnesium Sulfate 2 g IV over 10-15 minutes); Lidocaine 1.0-1.5 mg/kg IV bolus (second-line, especially in acute myocardial ischemia)

Red Flags & Clinical Pitfalls

  • !Mistaking wide-complex VT for SVT with aberrancy and administering Verapamil or Diltiazem (calcium channel blockers in VT cause precipitous vasodilation, myocardial depression, and fatal cardiac arrest!)
  • !Deterioration into pulseless VT or Ventricular Fibrillation (switch immediately to unsynchronized high-energy defibrillation 200 J biphasic and ACLS CPR algorithm)
  • !Severe refractory electrical storm (> 3 VT episodes within 24 hours requiring shocks; requires IV beta-blockers e.g. Esmolol, deep sedation, and emergent catheter ablation or stellate ganglion block)

Torsades de Pointes & Long QT Syndrome

ICD-10: I47.2Source: Braunwald's Heart Disease - Ch. 39

History & Clinical Examination Pearls

  • •Clinical presentation: Recurrent sudden syncope, episodic palpitations, seizures (frequently misdiagnosed as epilepsy), or sudden cardiac arrest
  • •Iatrogenic drug-induced triggers: Recent exposure to QT-prolonging medications: antiarrhythmics (amiodarone, sotalol, procainamide), psychotropics (haloperidol, quetiapine, citalopram, tricyclics), antimicrobials (azithromycin, ciprofloxacin, levofloxacin, fluconazole), or methadone
  • •Congenital vs Acquired: Family history of premature sudden cardiac death, congenital sensorineural deafness (Jervell and Lange-Nielsen syndrome) or Romano-Ward syndrome; acute triggers include severe hypokalemia, hypomagnesemia, severe bradycardia, or starvation
  • •Vital signs: Episodic severe bradycardia or marked sinus pause preceding arrhythmia ('short-long-short' sequence); pulse may be absent during paroxysms
  • •Cardiovascular signs: Normal baseline physical exam; during paroxysms: sudden syncope with cyanosis, tonic posturing, and undetectable blood pressure
  • •Post-cardioversion exam: Prolonged QT interval and prominent U waves or T-wave alternans observed on monitor

Diagnostic Tests & Paraclinics

  • •12-Lead Electrocardiogram: Baseline marked QTc prolongation (QTc > 500 ms, calculated via Bazett or Fridericia formula); pathological U waves, notched or biphasic T waves, macroscopic T-wave alternans
  • •Arrhythmia morphology: Polymorphic ventricular tachycardia with characteristically undulating QRS axis twisting around the isoelectric baseline ('twisting of the points') at a rate of 200-250 bpm, typically initiated by an early ventricular premature complex falling on the peak or down-slope of a prolonged T wave (R-on-T phenomenon) following a compensatory pause
  • •Serum Electrolyte Panel: Marked hypomagnesemia (serum Mg < 1.7 mg/dL) and hypokalemia (serum K < 4.0 mEq/L); check ionized calcium and thyroid function tests

Standard Inpatient Orders (100% Generic INN)

  • ✓Diet/Activity: Strict NPO, continuous telemetry with transcutaneous pacing pads placed on chest
  • ✓Monitoring: Continuous 12-lead ECG telemetry monitoring QTc interval, automated blood pressure every 2 minutes during active instability
  • ✓IV Hydration: 0.9% Normal Saline with added potassium and magnesium
  • ✓Pharmacotherapy (Generic Only): FIRST-LINE TREATMENT: Magnesium Sulfate 2 g IV bolus over 1-2 minutes (regardless of baseline serum magnesium level), followed by continuous IV infusion of 2-4 mg/min (Magnesium stabilizes the cardiac membrane by blocking early afterdepolarizations); REPEAT: Second bolus of Magnesium Sulfate 2 g IV in 5-10 minutes if TdP recurs; ACCELERATE HEART RATE TO SHORTEN QT: Isoproterenol continuous IV infusion at 1-10 mcg/min titrated to maintain heart rate 100-110 bpm (CONTRAINDICATED in congenital long QT!); OVERDRIVE TRANSVENOUS PACING: Temporary cardiac pacing at 100-120 bpm (treatment of choice for recurrent pause-dependent TdP); POTASSIUM REPLETION: Aggressively maintain serum potassium at 4.5-5.0 mEq/L with Potassium Chloride IV; WITHDRAW ALL QT-PROLONGING DRUGS immediately; ELECTRICAL DEFIBRILLATION: Unsynchronized defibrillation 200 J biphasic if TdP degenerates into sustained VF or hemodynamic collapse

Red Flags & Clinical Pitfalls

  • !Administering Class IA (procainamide), Class IC, or Class III (amiodarone, sotalol) antiarrhythmic drugs (fatal error: further prolongs QT and exacerbates Torsades de Pointes!)
  • !Degeneration into persistent Ventricular Fibrillation and asystolic cardiac arrest
  • !Failure to aggressively correct hypokalemia (K < 4.0 mEq/L) which perpetuates electrical instability

Complete Atrioventricular Heart Block (Third-Degree AV Block)

ICD-10: I44.2Source: Braunwald's Heart Disease - Ch. 37

History & Clinical Examination Pearls

  • •Clinical symptom complex: Sudden profound syncope (Stokes-Adams attacks), severe presyncope, extreme lightheadedness, fatigue, acute dyspnea, confusion, or sudden angina pectoris
  • •Etiological triggers: Acute inferior or anterior myocardial infarction (ischemic conduction necrosis), degenerative conduction system disease (Lenegre-Lev disease), AV nodal blocking drug toxicity (beta-blockers, diltiazem, verapamil, digoxin), acute myocarditis, Lyme disease, aortic valve endocarditis with root abscess, post-TAVR/surgical valve replacement
  • •Duration and stability: Sudden onset versus progressive worsening of first- or second-degree AV block
  • •Vital signs: Marked resting bradycardia (typically ventricular rate 20-40 bpm, regular), severe systolic hypertension with wide pulse pressure (due to increased stroke volume per beat) or profound hypotension
  • •Jugular venous pulse: Intermittent prominent, striking cannon 'a' waves occurring irregularly when the right atrium contracts against a closed tricuspid valve
  • •Auscultation: Variable intensity of the first heart sound (S1) from beat to beat depending on the fluctuating relationship between atrial and ventricular contraction; intermittent systolic murmurs and S4 gallop

Diagnostic Tests & Paraclinics

  • •12-Lead Electrocardiogram: Complete dissociation between P waves and QRS complexes (no constant PR interval); atrial rate (P-P interval) faster than ventricular rate (R-R interval); regular P-P intervals and regular R-R intervals independently
  • •Escape rhythm morphology: Narrow QRS complex (rate 40-55 bpm) suggests AV junctional escape above the bifurcation of the His bundle (more stable, responsive to atropine); Wide QRS complex (rate 20-40 bpm) indicates infranodal / ventricular escape (unstable, prone to asystole, resistant to atropine)
  • •Laboratory evaluation: Serum potassium, magnesium, calcium, cardiac troponin I/T, digoxin level, thyroid panel, Lyme serology

Standard Inpatient Orders (100% Generic INN)

  • ✓Diet/Activity: Strict NPO, complete bed rest with transcutaneous pacing pads placed immediately (anteroposterior placement)
  • ✓Monitoring: Continuous 12-lead ECG telemetry, continuous arterial line or automated blood pressure every 2-3 minutes, continuous pulse oximetry
  • ✓IV Hydration: 0.9% Normal Saline at 50-75 mL/hr maintenance
  • ✓Pharmacotherapy (Generic Only): FIRST-LINE PHARMACOLOGIC TRIAL: Atropine 1.0 mg IV bolus every 3-5 minutes (max 3.0 mg total); (Note: Atropine is effective only for nodal block; rarely effective and may cause worsening ischemia in infranodal wide-complex block!); SECOND-LINE CHRONOTROPIC INFUSIONS (Bridge to pacing): Dopamine continuous IV infusion at 5-20 mcg/kg/min OR Epinephrine continuous IV infusion at 2-10 mcg/min (titrated to achieve HR > 50 bpm and MAP > 65 mmHg) OR Isoproterenol 2-10 mcg/min IV infusion; DEFINITIVE ELECTRICAL THERAPY: Immediate Transcutaneous Pacing (set demand rate 60-70 bpm, increase current output until electrical and mechanical capture confirmed by femoral pulse); Urgent Transvenous Pacing wire placement in cardiac catheterization laboratory; PERMANENT PACEMAKER: Dual-chamber permanent pacemaker implantation once acute reversible causes are excluded

Red Flags & Clinical Pitfalls

  • !Administering lidocaine or other sodium channel blockers for wide-complex ventricular escape rhythm (suppresses the only life-sustaining escape pacemaker and causes fatal asystole!)
  • !Failure to confirm mechanical capture during transcutaneous pacing (electrical pacing spikes on monitor without corresponding arterial pulse / perfusion)
  • !Prolonged ventricular asystole or degenerating into pause-dependent Torsades de Pointes or ventricular fibrillation

Acute Infective Endocarditis

ICD-10: I33.0Source: Braunwald's Heart Disease - Ch. 73

History & Clinical Examination Pearls

  • •Clinical presentation: Acute high-grade fever, shaking chills, night sweats, anorexia, weight loss, progressive dyspnea, and rapid hemodynamic deterioration over days
  • •Predisposing risk factors: Prosthetic heart valves, prior history of endocarditis, indwelling central venous catheters, hemodialysis access, intravenous drug use (IVDU), recent invasive dental or urological procedures, structural congenital heart disease
  • •Embolic phenomena history: Acute focal neurological deficits (stroke from septic emboli), sudden back pain (vertebral osteomyelitis/discitis), sudden visual disturbance (Roth spots), painful digital nodules, or acute cold limb
  • •Cardiac examination: New or changing regurgitant heart murmur (aortic regurgitation or mitral regurgitation); signs of acute heart failure (elevated JVP, pulmonary crackles, S3 gallop)
  • •Immunological and vascular peripheral stigmata: Osler nodes (tender erythematous subcutaneous nodules on pads of fingers/toes); Janeway lesions (non-tender erythematous macules on palms/soles); splinter hemorrhages in nail beds; conjunctival petechiae
  • •Ophthalmologic & abdominal examination: Fundoscopic exam demonstrating Roth spots (retinal hemorrhages with pale central centers); palpable splenomegaly

Diagnostic Tests & Paraclinics

  • •Blood Cultures: Three separate sets of blood cultures drawn from different venipuncture sites with at least 1 hour between first and last draw before antimicrobial administration (major Duke criterion)
  • •Echocardiography: Urgent Transthoracic Echocardiogram (TTE) followed by Transesophageal Echocardiogram (TEE - sensitivity > 90-95%): demonstrates oscillating intracardiac vegetation on valve or supporting structures, leaflet perforation, perivalvular abscess, pseudoaneurysm, or new partial dehiscence of prosthetic valve
  • •Laboratory and Imaging: Leukocytosis with left shift, elevated ESR and C-reactive protein, microscopic hematuria and proteinuria (immune-complex glomerulonephritis); brain/abdominal CT to identify silent septic emboli

Standard Inpatient Orders (100% Generic INN)

  • ✓Diet/Activity: Bed rest, cardiac telemetry, high-calorie balanced nutrition
  • ✓Monitoring: Continuous cardiac telemetry (crucial to monitor PR interval for AV block indicating aortic root abscess extension!), daily physical exam for new murmurs or embolic signs, strict intake and output
  • ✓IV Hydration: 0.9% Normal Saline at maintenance (50-75 mL/hr); adjust carefully if heart failure present
  • ✓Pharmacotherapy (Generic Only): EMPIRIC ANTIMICROBIAL REGIMEN (NATIVE VALVE, ACUTE): Vancomycin 15-20 mg/kg IV every 8-12 hours (target trough 15-20 mcg/mL) PLUS Cefepime 2 g IV every 8 hours (or Ceftriaxone 2 g IV daily); EMPIRIC ANTIMICROBIAL REGIMEN (PROSTHETIC VALVE < 12 MONTHS): Vancomycin 15-20 mg/kg IV every 12 hours PLUS Gentamicin 1 mg/kg IV every 8 hours PLUS Rifampin 300 mg orally every 8 hours; TARGETED THERAPY: Tailor immediately upon identification of pathogen (e.g. Oxacillin/Nafcillin for MSSA, Ampicillin plus Gentamicin for Enterococcus); URGENT SURGICAL CONSULTATION: Emergent valve replacement surgery for: acute heart failure from valve destruction, uncontrolled infection/persistent bacteremia > 5-7 days, fungal endocarditis, abscess/fistula, or large mobile vegetation > 10 mm with embolic episodes

Red Flags & Clinical Pitfalls

  • !New PR-interval prolongation or new AV block on ECG indicating invasive perivalvular / aortic root abscess (absolute indication for emergency cardiac surgery)
  • !Acute severe acute valvular regurgitation with refractory pulmonary edema and cardiogenic shock requiring immediate surgical intervention
  • !Large mobile vegetations (> 10-15 mm) with recurrent major septic arterial embolization to brain or spleen

Acute Myopericarditis

ICD-10: I30.9Source: Braunwald's Heart Disease - Ch. 82

History & Clinical Examination Pearls

  • •Clinical symptom features: Sharp, pleuritic, retrosternal chest pain that characteristically worsens with inspiration, coughing, or lying flat (supine) and improves dramatically with sitting up and leaning forward
  • •Prodromal illness: Recent antecedent viral syndrome (1-3 weeks prior): fever, upper respiratory tract symptoms, gastroenteritis, malaise, or recent COVID-19 / mRNA vaccination
  • •Myocardial involvement indicators: Coexisting symptoms of myocardial injury: shortness of breath, unexplained fatigue, palpitations, orthopnea, or presyncope out of proportion to pain
  • •Pericardial friction rub: Pathognomonic superficial, scratchy, high-pitched triphasic (atrial systole, ventricular systole, early ventricular diastole) or biphasic auscultatory sound, heard best along left lower sternal border with patient leaning forward in expiration
  • •Signs of myocardial dysfunction: Resting tachycardia out of proportion to fever, third heart sound (S3 gallop), soft heart sounds, mild jugular venous distension
  • •Hemodynamic stability: Check for pulsus paradoxus and narrow pulse pressure to rule out evolving cardiac tamponade

Diagnostic Tests & Paraclinics

  • •12-Lead Electrocardiogram: Stage 1: Widespread, diffuse concave-upward ST-segment elevation across most limb and precordial leads (except aVR and V1) with reciprocal ST depression and PR depression in aVR; PR-segment depression in inferior/lateral leads (specific for pericardial inflammation); absence of reciprocal ST depression (unlike STEMI!)
  • •Cardiac Biomarkers: High-sensitivity cardiac Troponin I or T elevation (confirms myocardial involvement / myopericarditis as opposed to isolated pericarditis); elevated inflammatory markers (C-reactive protein, ESR, leukocytosis)
  • •Echocardiography & Cardiac MRI: TTE reveals small-to-moderate pericardial effusion, global or regional LV systolic wall motion abnormalities; Cardiac MRI (Lake Louise Criteria) shows myocardial edema on T2-weighted imaging and late gadolinium enhancement (LGE) in epicardial/mid-wall distribution

Standard Inpatient Orders (100% Generic INN)

  • ✓Diet/Activity: Restrict physical activity strictly to non-strenuous daily living until symptoms resolve and troponin/CRP normalize (avoid competitive sports for at least 3-6 months)
  • ✓Monitoring: Continuous cardiac telemetry for 24-48 hours (risk of ventricular arrhythmias in presence of myocardial necrosis), daily ECG, continuous pulse oximetry
  • ✓IV Hydration: 0.9% Normal Saline at maintenance (50 mL/hr)
  • ✓Pharmacotherapy (Generic Only): FIRST-LINE ANTI-INFLAMMATORY (PERICARDIAL COMPONENT): Colchicine 0.5 mg orally twice daily (0.5 mg once daily if weight < 70 kg or eGFR < 50 mL/min) for 3 months (dramatically reduces recurrence rates); PLUS NSAIDs: Ibuprofen 600 mg orally every 8 hours OR Aspirin 750-1000 mg orally every 8 hours for 1-2 weeks with gradual taper; (Note: In significant myocardial involvement / reduced LVEF, use cautious lower-dose NSAIDs or Aspirin, or low-dose Prednisone 0.2-0.5 mg/kg/day if NSAIDs contraindicated); GASTRIC PROTECTION: Omeprazole 20 mg orally daily; HEART FAILURE THERAPY: If LV systolic dysfunction develops: initiate Enalapril 2.5-5.0 mg orally daily and Metoprolol Succinate 12.5-25 mg daily once stabilized; AVOID STRENUOUS EXERCISE

Red Flags & Clinical Pitfalls

  • !Development of hemodynamic instability, pulsus paradoxus > 10 mmHg, or echocardiographic right ventricular collapse indicating evolving cardiac tamponade
  • !Severe ventricular arrhythmias (sustained VT or frequent polymorphic PVCs) secondary to extensive myocardial inflammation
  • !Rapidly worsening left ventricular ejection fraction (< 40%) or fulminant cardiogenic shock requiring inotropic support and mechanical circulatory assistance

Acute Decompensated Severe Aortic Stenosis

ICD-10: I35.0Source: Braunwald's Heart Disease - Ch. 68

History & Clinical Examination Pearls

  • •Classic symptom triad (SAD): Syncope (exertional), Angina pectoris (even in the absence of CAD due to severe LVH and supply-demand mismatch), and Dyspnea / Heart Failure (marks onset of decompensation with median survival < 2 years without intervention)
  • •Acute decompensation precipitants: Acute onset atrial fibrillation (loss of 25-30% atrial kick into non-compliant LV causes immediate collapse), acute volume overload, infection/sepsis, or severe anemia
  • •Prior history: Known calcific bicuspid or degenerative senile aortic valve disease, previous exertional presyncope
  • •Pulse characteristics (Pulsus Parvus et Tardus): Carotid pulse volume is characteristically small and rate of rise is delayed and slurred, best appreciated on carotid palpation
  • •Murmur features: Harsh, late-peaking crescendo-decrescendo systolic ejection murmur heard best at the second right intercostal space, radiating intensely to carotids; single or paradoxically split second heart sound (S2), soft or absent aortic component (A2), prominent S4 gallop
  • •Signs of acute decompensation: Severe pulmonary rales, tachypnea, narrow pulse pressure (e.g. BP 95/75 mmHg), cool extremities

Diagnostic Tests & Paraclinics

  • •Transthoracic Echocardiography (Diagnostic Benchmark): Severe aortic stenosis criteria: Aortic valve area (AVA) <= 1.0 cm2 (or indexed AVA <= 0.6 cm2/m2); Peak aortic jet velocity >= 4.0 m/s; Mean transaortic pressure gradient >= 40 mmHg; heavily calcified, immobile aortic valve leaflets; concentric left ventricular hypertrophy
  • •12-Lead Electrocardiogram: Left ventricular hypertrophy with secondary repolarization abnormalities ('strain pattern' ST depression and T-wave inversion in leads I, aVL, V5-V6); left atrial enlargement; left bundle branch block
  • •Chest Radiography: Post-stenotic dilation of the ascending aorta, prominent aortic valve calcification, pulmonary venous congestion and interstitial pulmonary edema

Standard Inpatient Orders (100% Generic INN)

  • ✓Diet/Activity: Strict bed rest, semi-fowler position, strict low-sodium diet, continuous telemetry
  • ✓Monitoring: Continuous arterial line for accurate beat-to-beat BP monitoring, pulse oximetry, strict hourly urine output via Foley catheter
  • ✓IV Hydration: EXTREME CAUTION WITH FLUID BALANCE: Non-compliant hypertrophied LV requires adequate preload to maintain stroke volume, but excessive fluid precipitates severe pulmonary edema; avoid both hypovolemia and hypervolemia
  • ✓Pharmacotherapy (Generic Only): DEFINITIVE URGENT INTERVENTION: Urgent cardiothoracic surgery or interventional cardiology consultation for Surgical Aortic Valve Replacement (SAVR) or Transcatheter Aortic Valve Implantation (TAVI); emergent balloon aortic valvuloplasty as a bridge to TAVI if critically unstable; ACUTE PULMONARY EDEMA MANAGEMENT: Low-dose Furosemide 20-40 mg IV bolus with extreme caution (aggressive diuresis drops preload and causes profound hypotension); VASODILATOR PRECAUTION: Vasodilators (Nitroglycerin, Nitroprusside, ACE inhibitors) are RELATIVELY CONTRAINDICATED in severe fixed LVOT obstruction; if severe hypertension persists, cautious low-dose Nitroprusside in ICU with arterial line; ATRIAL FIBRILLATION CONVERSION: Immediate electrical cardioversion for acute AF to restore sinus rhythm and atrial booster pump; INOTROPIC BRIDGE: Norepinephrine continuous IV infusion for shock

Red Flags & Clinical Pitfalls

  • !Administering aggressive vasodilators (Nitroglycerin, Nitroprusside, Hydralazine, ACEi) causing sudden profound uncorrectable systemic hypotension and fatal coronary hypoperfusion
  • !Sudden onset Atrial Fibrillation with loss of atrial kick precipitating instantaneous pulmonary edema and cardiogenic shock
  • !Exertional or post-tussive syncope in severe AS signaling imminent sudden cardiac death

Acute Mitral Regurgitation Secondary to Chordal Rupture

ICD-10: I34.0Source: Braunwald's Heart Disease - Ch. 69

History & Clinical Examination Pearls

  • •Onset characteristics: Catastrophic sudden onset of severe dyspnea, orthopnea, air hunger, and pink frothy sputum in a previously asymptomatic or mildly symptomatic individual
  • •Predisposing conditions: Myxomatous mitral valve disease (mitral valve prolapse), infective endocarditis with leaflet/chordal destruction, acute myocardial infarction (papillary muscle rupture), blunt chest trauma, or systemic connective tissue disorders (Marfan, Ehlers-Danlos)
  • •Pathophysiologic mechanism: Sudden volume overload into a small, non-compliant, normal-sized left atrium, causing precipitous transmission of high pressures back into pulmonary capillaries
  • •Cardiac auscultation: Decrescendo early-to-mid systolic murmur (frequently harsh, terminating well before S2 as left atrial pressure rapidly equilibrates with LV systolic pressure; UNLIKE the holosystolic murmur of chronic MR!); widely split S2; prominent S3 and S4 gallops
  • •Precordial palpation: Hyperdynamic apical impulse without displacement, absence of chronic cardiomegaly; right ventricular heave due to acute severe pulmonary hypertension
  • •Respiratory and hemodynamic findings: Florid bilateral pulmonary crackles from bases to apices, severe tachypnea, resting tachycardia, profound hypotension, cool cyanotic extremities

Diagnostic Tests & Paraclinics

  • •Transthoracic & Transesophageal Echocardiography: TEE is diagnostic: demonstrates flail mitral valve leaflet with torn chordae tendineae whipping freely into the left atrium during systole; severe eccentric mitral regurgitation jet (vena contracta >= 0.7 cm, effective regurgitant orifice area >= 0.40 cm2); small-to-normal left atrial size; hyperdynamic LV function initially
  • •Chest Radiography: Severe interstitial and alveolar pulmonary edema, characteristically asymmetric (frequently preferential right upper lobe pulmonary edema due to eccentric regurgitant jet directed toward right pulmonary veins!); normal-sized cardiac silhouette
  • •12-Lead Electrocardiogram: Sinus tachycardia; absence of chronic left atrial enlargement or LV hypertrophy (distinguishes acute from chronic MR); may show ischemic changes if papillary muscle necrosis

Standard Inpatient Orders (100% Generic INN)

  • ✓Diet/Activity: Strict NPO, intensive care unit admission, upright sitting position with legs dangling
  • ✓Monitoring: Arterial line for continuous BP, continuous pulse oximetry, Foley catheter for strict hourly urine output, central venous catheter
  • ✓IV Hydration: STRICT FLUID RESTRICTION; avoid all IV crystalloid boluses
  • ✓Pharmacotherapy (Generic Only): DEFINITIVE TREATMENT: Emergent surgical consultation for immediate mitral valve repair or replacement (chordal reconstruction or prosthetic valve); AFTERLOAD REDUCTION (IF SBP > 90-100 mmHg): Sodium Nitroprusside continuous IV infusion starting at 0.5 mcg/kg/min titrated up to 3-5 mcg/kg/min (markedly reduces regurgitant fraction and increases forward stroke volume); Nitroglycerin IV infusion 10-200 mcg/min for preload reduction; DIURESIS: Furosemide 40-80 mg IV bolus to treat alveolar pulmonary edema; MECHANICAL CIRCULATORY SUPPORT: Intra-Aortic Balloon Pump (IABP) placement (reduces afterload, increases forward cardiac output, and augments coronary perfusion as an ideal bridge to emergent surgery); VASOPRESSOR: Norepinephrine continuous IV infusion if SBP < 85 mmHg

Red Flags & Clinical Pitfalls

  • !Failure to recognize the murmur because it is early-to-mid systolic and decrescendo (mistaking acute MR for aortic stenosis or innocent murmur)
  • !Asymmetric right upper lobe pulmonary edema misdiagnosed as focal pneumonia, delaying life-saving surgical intervention
  • !Cardiogenic shock and pulmonary capillary rupture leading to massive pulmonary hemorrhage and asphyxiation

Hypertrophic Cardiomyopathy with Dynamic LVOT Obstruction

ICD-10: I42.1Source: Braunwald's Heart Disease - Ch. 53

History & Clinical Examination Pearls

  • •Clinical presentation: Exertional dyspnea, fatigue, atypical or typical angina, post-exertional presyncope or syncope, and palpitations
  • •Exacerbating dynamic factors: Symptoms worsen significantly after meals, with dehydration, physical exertion, Valsalva maneuver, standing up, or exposure to vasodilators or inotropes (which increase the LVOT gradient)
  • •Family history: Autosomal dominant genetic transmission (sarcomeric protein mutations: MYH7, MYBPC3); strong family history of unexplained premature sudden cardiac death in young first-degree relatives
  • •Arterial pulse characteristics (Pulsus Bisferiens): Brisk, spike-and-dome carotid pulse (rapid initial ejection followed by midsystolic obstruction and secondary pressure wave)
  • •Dynamic murmur auscultation: Harsh crescendo-decrescendo systolic murmur at the left lower sternal border and apex: INCREASES in intensity with maneuvers that decrease LV cavity size (Valsalva strain phase, standing, amyl nitrite, dehydration); DECREASES with maneuvers that increase LV volume or afterload (squatting, handgrip, passive leg raise)
  • •Apical impulse: Sustained, double or triple apical impulse (presystolic impulse corresponding to vigorous atrial contraction against stiff non-compliant LV, S4 gallop)

Diagnostic Tests & Paraclinics

  • •Transthoracic Echocardiography: Asymmetric septal hypertrophy (interventricular septum thickness >= 15 mm, or >= 13 mm with positive family history; septal-to-posterior wall ratio > 1.3-1.5); Systolic Anterior Motion (SAM) of the anterior mitral valve leaflet with septal contact; dynamic peak LVOT gradient >= 30 mmHg at rest or >= 50 mmHg with provocation (Valsalva); secondary eccentric posterior mitral regurgitation
  • •12-Lead Electrocardiogram: Marked left ventricular hypertrophy with deeply inverted T waves in lateral/precordial leads ('giant negative T waves' in Yamaguchi apical variant); prominent dagger-like narrow Q waves in lateral leads (I, aVL, V5-V6) representing septal depolarization; left atrial enlargement
  • •Continuous Holter Monitoring: Identifies non-sustained ventricular tachycardia (NSVT), a major independent risk factor for sudden cardiac death

Standard Inpatient Orders (100% Generic INN)

  • ✓Diet/Activity: Avoid dehydration, avoid large heavy meals, strict avoidance of competitive sports, burst exertion, and heavy isometric straining
  • ✓Monitoring: Continuous cardiac telemetry, noninvasive blood pressure, pulse oximetry
  • ✓IV Hydration: 0.9% Normal Saline 500-1000 mL IV bolus for acute hypotension or increased gradient (expanding LV cavity volume reduces SAM and relieves obstruction)
  • ✓Pharmacotherapy (Generic Only): FIRST-LINE MEDICAL THERAPY (NEGATIVE INOTROPES/CHRONOTROPES): Metoprolol 25-50 mg orally every 12 hours titrated to resting HR 55-60 bpm (prolongs diastole, increases LV filling, reduces contractility and dynamic gradient) OR Propranolol 40-80 mg every 8 hours; SECOND-LINE / ALTERNATIVE: Verapamil 40-80 mg orally three times daily (cautious use; contraindicated if severe resting gradient > 80 mmHg or pulmonary edema) OR Disopyramide 100-200 mg orally every 8 hours (potent negative inotrope, highly effective combined with beta-blockers); NOVEL MYOSIN INHIBITOR: Mavacamten 5 mg orally daily (titrated with echocardiographic guidance); REFRACTORY SYMPTOMATIC OBSTRUCTION: Surgical septal myectomy (Morrow procedure) or Alcohol Septal Ablation; STRICTLY CONTRAINDICATED MEDICATIONS: Positive inotropes (Dobutamine, Dopamine, Digoxin) and pure vasodilators (Nitroglycerin, Nitroprusside, Dihydropyridine CCBs, PDE-5 inhibitors) MUST BE AVOIDED!

Red Flags & Clinical Pitfalls

  • !Administering inotropes (Dobutamine, Dopamine) or vasodilators (Nitrates) causing catastrophic worsening of LVOT obstruction, acute shock, and cardiac arrest
  • !Exertional syncope or documented non-sustained ventricular tachycardia indicating high risk of sudden cardiac death (requires urgent evaluation for Implantable Cardioverter-Defibrillator / ICD)
  • !Severe dehydration or acute blood loss triggering acute hemodynamic collapse due to cavity obliteration

Takotsubo Cardiomyopathy (Stress-Induced Cardiomyopathy)

ICD-10: I42.8Source: Braunwald's Heart Disease - Ch. 54

History & Clinical Examination Pearls

  • •Triggering event: Acute profound emotional stress (death of a loved one, severe interpersonal conflict, panic attack) or severe physical stress (critical illness, major surgery, severe pain, stroke, asthma attack) immediately preceding symptoms (80-90% of cases)
  • •Demographics & symptoms: Postmenopausal females (approx 90% of cases; mean age 65-70 years) presenting with acute crushing retrosternal chest pain, sudden dyspnea, diaphoresis, or syncope mimicking acute STEMI
  • •Absence of prior CAD: Typically lacks known obstructive coronary artery disease
  • •Vital signs and perfusion: Tachycardia, hypotension indicating pump failure or dynamic LVOT obstruction, tachypnea, cool extremities
  • •Cardiovascular auscultation: Bilateral pulmonary crackles, S3 and S4 gallops, transient systolic ejection murmur (if dynamic left ventricular outflow tract obstruction develops)
  • •Signs of acute decompensation: Acute pulmonary edema and cardiogenic shock occur in 10-15% of patients during the acute phase

Diagnostic Tests & Paraclinics

  • •12-Lead Electrocardiogram: Acute phase: ST-segment elevation (typically leads V2-V5, mimics anterior STEMI without reciprocal changes); Subacute phase (24-48 hours): deep, widespread, symmetric T-wave inversions with marked QTc prolongation (> 500 ms; high risk for Torsades de Pointes!)
  • •Cardiac Biomarkers: Mild-to-moderate elevation of high-sensitivity cardiac troponin with disproportionately massive elevation of natriuretic peptides (BNP / NT-proBNP), reflecting extensive apical myocardial wall stress
  • •Urgent Coronary Angiography & Left Ventriculography: Diagnostic hallmark (Mayo Clinic Criteria): Absence of obstructive coronary artery disease (> 50% stenosis) or culprit plaque rupture; Left ventriculogram shows classic apical and mid-ventricular ballooning with basal hypercontractility (resembling a Japanese octopus trap / takotsubo)

Standard Inpatient Orders (100% Generic INN)

  • ✓Diet/Activity: Bed rest, continuous cardiac telemetry in a quiet, low-stress environment
  • ✓Monitoring: Continuous 12-lead ECG telemetry (monitor QTc interval daily for prolongation), arterial line if hemodynamically unstable, pulse oximetry
  • ✓IV Hydration: Cautious crystalloids if dynamic LVOT obstruction is present with hypovolemia; avoid fluid overload if pulmonary edema
  • ✓Pharmacotherapy (Generic Only): IF STABLE WITH LVEF DEPRESSION: Guideline-directed heart failure therapy: Enalapril 2.5-5 mg orally daily (or Lisinopril) PLUS Metoprolol Tartrate 25 mg twice daily; Diuresis with Furosemide 20-40 mg IV for pulmonary congestion; ANTICOAGULATION: Unfractionated Heparin or Enoxaparin 1 mg/kg SC every 12 hours if apical akinesis is severe (high risk of left ventricular mural thrombus and stroke until recovery); IF CARDIOGENIC SHOCK WITH DYNAMIC LVOT OBSTRUCTION: BETA-BLOCKERS (Esmolol IV infusion or Metoprolol) AND FLUID LOADING; STRICTLY AVOID INOTROPES (Dobutamine, Dopamine, Milrinone) which exacerbate apical ballooning and LVOT obstruction; if inotrope needed for shock without LVOT obstruction, consider Levosimendan or mechanical circulatory support (Impella/VA-ECMO)

Red Flags & Clinical Pitfalls

  • !Administering inotropes (Dobutamine) in the presence of dynamic LVOT obstruction (triggers profound shock, mitral regurgitation, and death)
  • !Severe QTc prolongation (> 550 ms) triggering pause-dependent Torsades de Pointes or ventricular fibrillation
  • !Left ventricular apical thrombus formation with embolic cerebrovascular accident (stroke)

Paroxysmal Supraventricular Tachycardia (AVNRT)

ICD-10: I47.1Source: Braunwald's Heart Disease - Ch. 38

History & Clinical Examination Pearls

  • •Onset and termination characteristics: Sudden, abrupt 'on/off' paroxysmal palpitations ('light switch' phenomenon) described as rapid, regular fluttering or pounding in the chest or throat ('frog sign')
  • •Demographics and triggers: Most common regular SVT in humans; predilection for young to middle-aged females without structural heart disease; triggered by caffeine, alcohol, nicotine, psychological stress, fatigue, sudden bending forward, or fever
  • •Associated symptoms: Lightheadedness, anxiety, shortness of breath, polyuria during or following termination (due to atrial distension and atrial natriuretic peptide / ANP release), neck pulsations
  • •Vital signs: Extremely rapid, perfectly regular heart rate typically 150-250 bpm; blood pressure may show mild transient hypotension or remain normal
  • •Neck examination: Rapid, regular, continuous fluttering venous pulsations in the jugular veins ('frog sign' caused by simultaneous atrial and ventricular contraction against closed tricuspid valve)
  • •Cardiac auscultation: Perfectly regular rapid heart sounds, normal S1 and S2, absence of gallops or murmurs unless underlying valve disease

Diagnostic Tests & Paraclinics

  • •12-Lead Electrocardiogram: Narrow QRS complex tachycardia (< 120 ms, regular R-R intervals); heart rate 140-220 bpm; absence of distinct P waves prior to QRS; Pseudo-r' wave in lead V1 and pseudo-S wave in inferior leads (II, III, aVF) representing retrograde P wave buried inside or immediately following the terminal QRS complex (RP interval < 70 ms in typical slow-fast AVNRT)
  • •Electrolytes and Thyroid: Serum potassium, magnesium, calcium, and TSH to exclude secondary exacerbating causes
  • •Post-termination ECG: Normal sinus rhythm with normal PR and QT intervals; absence of delta waves (excludes baseline pre-excitation / WPW)

Standard Inpatient Orders (100% Generic INN)

  • ✓Diet/Activity: Bed rest during episode, continuous telemetry; avoid caffeine, nicotine, and adrenergic stimulants
  • ✓Monitoring: Continuous 12-lead ECG telemetry monitoring during diagnostic and therapeutic maneuvers, continuous blood pressure and SpO2
  • ✓IV Hydration: 0.9% Normal Saline at 50 mL/hr KVO
  • ✓Pharmacotherapy (Generic Only): FIRST-LINE NON-PHARMACOLOGIC: Modified Valsalva Maneuver (strain at 40 mmHg for 15 seconds in semi-recumbent position, followed by immediate supine repositioning and passive leg elevation to 45 degrees for 15 seconds; converts > 40% of cases) OR unilateral Carotid Sinus Massage for 5-10 seconds (after confirming absence of carotid bruits); FIRST-LINE PHARMACOLOGIC: Adenosine 6 mg rapid IV push through large-bore antecubital vein followed immediately by 20 mL Normal Saline flush; if not converted within 1-2 minutes: Adenosine 12 mg rapid IV push; SECOND-LINE PHARMACOLOGIC: Verapamil 2.5-5.0 mg IV bolus over 2 minutes (repeat 5-10 mg in 15-30 min if needed) OR Diltiazem 0.25 mg/kg IV bolus over 2 minutes OR Metoprolol 2.5-5.0 mg IV bolus every 5 minutes up to 15 mg; IF HEMODYNAMICALLY UNSTABLE: Immediate Synchronized Direct Current Cardioversion (DCCV) at 50-100 J biphasic under IV sedation; DEFINITIVE CURE: Catheter ablation of slow pathway

Red Flags & Clinical Pitfalls

  • !Administering Adenosine in severe bronchospastic asthma (can precipitate life-threatening bronchospasm; use Verapamil or Diltiazem instead)
  • !Failure to use a rapid saline flush after Adenosine (Adenosine half-life is < 10 seconds; slow injection results in drug inactivation before reaching cardiac receptors)
  • !Performing bilateral simultaneous carotid sinus massage (can cause cerebral ischemia or prolonged asystole)

Ventricular Fibrillation & Pulseless Cardiac Arrest

ICD-10: I49.01Source: Braunwald's Heart Disease - Ch. 44

History & Clinical Examination Pearls

  • •Sudden collapse: Catastrophic, instantaneous loss of consciousness without warning, agonal breathing ('gasping'), and immediate loss of arterial pulse
  • •Preceding events: Acute coronary syndrome (plaque rupture with acute ischemia is the trigger in 70-80%), severe electrolyte abnormalities (hypokalemia, hypomagnesemia), electrocution, drowning, drug toxicity (antiarrhythmics, cocaine), or progression from sustained VT
  • •Time-critical window: Survival declines by 7-10% for every minute of delayed defibrillation without high-quality CPR
  • •Immediate assessment (within 10 seconds): Unresponsive patient, absence of normal breathing (apnea or agonal gasps only), absence of central carotid or femoral pulse
  • •Skin and perfusion: Gray, cyanotic, cold skin, fixed or dilated pupils within minutes of circulatory arrest
  • •Post-ROSC examination: Glasgow Coma Scale, pupillary light reflex, corneal reflexes, myoclonus, cardiovascular stability, sternal crunch/rib fractures from CPR

Diagnostic Tests & Paraclinics

  • •Cardiac Monitor / 12-Lead Rhythm Strip: Completely chaotic, irregular, disorganized waveforms without recognizable P waves, QRS complexes, or T waves; Coarse VF: high-amplitude fibrillatory waves (> 0.2 mV; highly responsive to defibrillation); Fine VF: low-amplitude waveforms (< 0.2 mV; indicates prolonged arrest, severe ischemia, and depleted cellular ATP; easily mistaken for asystole)
  • •Point-of-Care Capnography (End-Tidal CO2 / PetCO2): Continuous quantitative waveform capnography: PetCO2 < 10 mmHg indicates inadequate chest compressions; sudden persistent jump in PetCO2 >= 35-40 mmHg is a definitive indicator of Return of Spontaneous Circulation (ROSC)
  • •Post-ROSC Diagnostics: Immediate 12-lead ECG (evaluate for STEMI requiring emergent coronary angiography), point-of-care arterial blood gas (severe mixed metabolic/lactic acidosis), electrolytes, cardiac troponin, bedside echocardiogram

Standard Inpatient Orders (100% Generic INN)

  • ✓Diet/Activity: Strict NPO, flat supine on hard backboard, continuous uninterrupted chest compressions (100-120/min, depth 5-6 cm, full chest recoil)
  • ✓Monitoring: Continuous waveform capnography (PetCO2), continuous cardiac defibrillator rhythm monitoring, automated BP and pulse oximetry post-ROSC
  • ✓IV Hydration: 0.9% Normal Saline or Balanced Crystalloids IV bolus 1000-2000 mL for post-arrest hypotension
  • ✓Pharmacotherapy (Generic Only): FIRST PRIORITY / SHOCKABLE RHYTHM: Immediate Unsynchronized High-Energy Defibrillation: 200 J biphasic (or 360 J monophasic); resume CPR immediately for 2 minutes without rhythm check; RESUSCITATION MEDICATIONS: Epinephrine 1 mg IV/IO every 3-5 minutes (after second unsuccessful shock); ANTIARRHYTHMICS (AFTER 3RD SHOCK): Amiodarone 300 mg IV/IO rapid bolus, second dose 150 mg IV/IO after next shock OR Lidocaine 1.0-1.5 mg/kg IV/IO first dose, then 0.5-0.75 mg/kg; REVERSIBLE CAUSES (Hs & Ts): Hypoxia, Hypovolemia, Hydrogen ion (acidosis), Hypo/Hyperkalemia, Hypothermia, Tension pneumothorax, Tamponade, Toxins, Thrombosis pulmonary, Thrombosis coronary; POST-ROSC TARGETED TEMPERATURE MANAGEMENT: Maintain strict normothermia 32-36°C for >= 24 hours; Norepinephrine IV infusion for post-cardiac arrest shock (target MAP >= 65 mmHg); immediate coronary angiography

Red Flags & Clinical Pitfalls

  • !Interrupting chest compressions for > 10 seconds during rhythm analysis or vascular access (collapses coronary perfusion pressure)
  • !Hyperventilation during CPR (increases intrathoracic pressure, decreases venous return, decreases cardiac output and cerebral blood flow)
  • !Mistaking fine ventricular fibrillation for asystole and omitting life-saving electrical defibrillation

Acute Pulmonary Arterial Hypertension Crisis

ICD-10: I27.0Source: Braunwald's Heart Disease - Ch. 86

History & Clinical Examination Pearls

  • •Precipitating triggers: Sepsis/infection, acute hypoxemia, hypercapnia, metabolic acidosis, abrupt discontinuation of pulmonary vasodilator therapy (e.g. prostacyclins, sildenafil, bosentan), pulmonary embolism, anesthesia induction, or pregnancy
  • •Clinical presentation: Acute worsening dyspnea, extreme fatigue, presyncope or syncope with minimal exertion, severe retrosternal chest tightness (RV angina), and abdominal distension
  • •Underlying classification: Idiopathic PAH, connective tissue disease (systemic sclerosis), congenital heart disease with Eisenmenger syndrome, or chronic thromboembolic pulmonary hypertension (CTEPH)
  • •Cardiovascular auscultation: Loud, booming, palpable pulmonary component of second heart sound (P2); prominent right-sided S3 and S4 gallops; high-pitched early diastolic decrescendo murmur of pulmonary regurgitation (Graham Steell murmur); holosystolic tricuspid regurgitation murmur augmenting with inspiration (Carvallo sign)
  • •Jugular venous pulse: Strikingly elevated JVP with prominent, giant 'a' waves (vigorous right atrial contraction against stiff RV) and prominent 'v' waves (severe tricuspid regurgitation)
  • •Hemodynamic profile: Severe hypotension, narrow pulse pressure, cold mottled extremities, peripheral cyanosis, tender pulsatile hepatomegaly, and ascites

Diagnostic Tests & Paraclinics

  • •Echocardiography: Massive right ventricular dilation and hypertrophy; severe RV systolic dysfunction (TAPSE < 16 mm, RV fractional area change < 35%); severe tricuspid regurgitation with peak TR jet velocity > 3.5-4.0 m/s; flattened interventricular septum bowing into left ventricle during systole ('D-shaped' left ventricle), impairing LV filling and forward stroke volume
  • •12-Lead Electrocardiogram: Right axis deviation (> +90°); right ventricular hypertrophy (tall R wave in V1 > 7 mm, R/S ratio > 1 in V1); right atrial enlargement (P pulmonale > 2.5 mm in lead II); RV strain pattern (ST depression and T-wave inversion in V1-V4 and inferior leads)
  • •Arterial Blood Gas & Right Heart Catheterization: Hypoxemia (PaO2 < 60 mmHg), respiratory/metabolic acidosis; RHC shows mean pulmonary arterial pressure (mPAP) > 20 mmHg (often > 50-60 mmHg during crisis) with pulmonary vascular resistance (PVR) > 3-5 Wood Units and elevated right atrial pressure (> 15 mmHg)

Standard Inpatient Orders (100% Generic INN)

  • ✓Diet/Activity: Strict NPO, intensive care unit admission, minimize all unnecessary stimulation, maintain body temperature (avoid hypothermia and shivering)
  • ✓Monitoring: Continuous arterial line for blood pressure, central venous catheter for CVP and ScvO2, continuous pulse oximetry, strict Foley hourly urine output
  • ✓IV Hydration: STRICT AVOIDANCE OF AGGRESSIVE FLUID LOADING: The failing, dilated RV is volume-intolerant; excessive fluid shifts the interventricular septum further into the LV, worsening LV collapse; cautious diuresis or euvolemia
  • ✓Pharmacotherapy (Generic Only): FIRST-LINE PULMONARY VASODILATOR: Inhaled Nitric Oxide (iNO) 20-40 ppm continuously OR Inhaled Epoprostenol 10-50 ng/kg/min (selectively dilates pulmonary vasculature without causing systemic hypotension); SYSTEMIC VASOPRESSOR / RV INOTROPE: Norepinephrine continuous IV infusion 0.05-0.2 mcg/kg/min (restores systemic BP and RV coronary perfusion pressure) PLUS Dobutamine 2.5-5.0 mcg/kg/min or Milrinone 0.25-0.5 mcg/kg/min (augments RV inotropy; avoid high doses that worsen vasodilation); ORAL/IV SPECIFIC VASODILATORS: Continue baseline targeted PAH medications; Sildenafil 20 mg orally/IV every 8 hours, Treprostinil IV/SC; MECHANICAL SUPPORT: Veno-arterial ECMO as an emergent bridge to lung transplantation or recovery

Red Flags & Clinical Pitfalls

  • !Aggressive intravenous fluid boluses in RV failure (precipitates acute RV dilation, fatal septal shifting, LV compression, and instantaneous cardiac arrest)
  • !Emergency endotracheal intubation without experienced personnel (sedation causes vasoplegia and positive pressure ventilation crushes RV venous return and RV output, frequently triggering fatal arrest)
  • !Abrupt cessation of continuous IV/subcutaneous Prostacyclin infusions (causes rebound acute pulmonary vasoconstriction and death within hours)

Wolff-Parkinson-White Syndrome with Pre-Excited Atrial Fibrillation

ICD-10: I45.6Source: Braunwald's Heart Disease - Ch. 38

History & Clinical Examination Pearls

  • •Clinical presentation: Sudden catastrophic onset of extremely rapid palpitations, dizziness, syncope, acute chest pain, dyspnea, or sudden cardiovascular collapse in a young patient
  • •Electrophysiologic substrate: Presence of an accessory atrioventricular pathway (Bundle of Kent) conducting anterogradely from atria to ventricles without the decremental conduction delay of the AV node
  • •Arrhythmia mechanism: Atrial fibrillation occurs in 20-30% of WPW patients; the non-decremental accessory pathway can conduct fibrillatory impulses 1:1 at rates > 250-300 bpm directly to the ventricles
  • •Vital signs: Extremely rapid, irregular radial pulse, often so rapid (> 200-300 bpm) that peripheral pulses are weak, thready, or non-palpable
  • •Hemodynamic status: Rapidly progressive hypotension, diaphoresis, cold clammy extremities, syncope, or confusion
  • •Cardiovascular auscultation: Muffled, chaotic, extremely rapid heart sounds without discernible rhythm

Diagnostic Tests & Paraclinics

  • •12-Lead Electrocardiogram (Classic Diagnostic Triad): 1) Rapid, irregularly irregular rhythm, 2) Wide and bizarre QRS complexes (due to variable fusion between accessory pathway conduction and normal His-Purkinje conduction), 3) Extremely short R-R intervals (shortest pre-excited R-R interval < 250 ms, often < 200 ms); easily misdiagnosed as polymorphic VT
  • •Serum Electrolytes: Urgent serum potassium, magnesium, calcium, and blood gas
  • •Post-Conversion ECG: Classic WPW triad in sinus rhythm: Short PR interval (< 120 ms), slurred initial upstroke of QRS (Delta wave), and prolonged QRS duration (> 120 ms)

Standard Inpatient Orders (100% Generic INN)

  • ✓Diet/Activity: Strict NPO, immediate bed rest with defibrillator pads attached to chest
  • ✓Monitoring: Continuous 12-lead ECG telemetry, continuous automated BP every 2 minutes, pulse oximetry
  • ✓IV Hydration: 0.9% Normal Saline at 50 mL/hr KVO
  • ✓Pharmacotherapy (Generic Only): FIRST-LINE / DEFINITIVE THERAPY (IF UNSTABLE OR HIGH RISK): Immediate Synchronized Direct Current Cardioversion (DCCV) at 100-200 J biphasic (or immediate unsynchronized shock if synchronization fails due to rapid bizarre QRS complexes) under rapid IV sedation (Etomidate 0.1-0.2 mg/kg); IF HEMODYNAMICALLY STABLE: Procainamide 20-50 mg/min IV infusion (up to 17 mg/kg maximum load) OR Ibutilide 1 mg IV over 10 minutes (blocks accessory pathway conduction and slows ventricular response); ABSOLUTE CONTRAINDICATIONS: ALL AV NODAL BLOCKING DRUGS (Adenosine, Beta-blockers, Diltiazem, Verapamil, Digoxin, IV Amiodarone) ARE STRICTLY CONTRAINDICATED! (Blocking the AV node diverts all fibrillatory traffic down the accessory pathway, precipitating instantaneous Ventricular Fibrillation and death!); DEFINITIVE THERAPY: Catheter radiofrequency ablation of the accessory pathway

Red Flags & Clinical Pitfalls

  • !Administering AV nodal blockers (Adenosine, Metoprolol, Diltiazem, Verapamil, Digoxin) causing immediate degeneration into fatal Ventricular Fibrillation
  • !Shortest pre-excited R-R interval < 250 ms (identifies ultra-high-risk accessory pathway with imminent risk of sudden cardiac death)
  • !Misdiagnosing pre-excited AF as regular SVT with aberrancy or monomorphic VT and giving contraindicated drugs

Sick Sinus Syndrome (Tachycardia-Bradycardia Syndrome)

ICD-10: I49.5Source: Braunwald's Heart Disease - Ch. 37

History & Clinical Examination Pearls

  • •Clinical presentation: Alternating episodes of rapid palpitations (due to paroxysmal atrial tachyarrhythmias, AF, or atrial flutter) followed immediately by severe lightheadedness, presyncope, or sudden prolonged syncope (Stokes-Adams attack) upon abrupt termination of tachycardia
  • •Chronic insidious symptoms: Chronic fatigue, exertional dyspnea, memory lapses, cognitive impairment, and exercise intolerance due to chronotropic incompetence
  • •Demographics & risk factors: Predominantly elderly patients (> 65-70 years) with idiopathic fibrodegenerative disease of the SA node; exacerbated by CAD, hypertension, cardiomyopathy, or amyloidosis
  • •Pulse characteristics: Alternating between severe persistent sinus bradycardia (HR < 40-50 bpm), prolonged sinus pauses (> 3 seconds), and sudden episodes of rapid irregular tachycardia (HR 130-160 bpm)
  • •Postural signs: Orthostatic hypotension, pale skin, diminished peripheral perfusion during bradycardic pauses
  • •Cardiovascular auscultation: Variable heart rate and rhythm; absence of significant new murmurs unless concomitant valvular disease

Diagnostic Tests & Paraclinics

  • •12-Lead Electrocardiogram & Holter Monitoring: Severe sinus bradycardia; sinus arrest or sinoatrial exit block with pauses > 3 seconds; alternating with paroxysms of Atrial Fibrillation, Atrial Flutter, or Atrial Tachycardia; characteristically prolonged asystolic sinus pause upon spontaneous termination of tachycardia ('overdrive suppression of diseased sinus node')
  • •Laboratory Evaluation: Thyroid function tests (rule out severe hypothyroidism), serum electrolytes (potassium, magnesium, calcium), medication levels (digoxin level)
  • •Echocardiography: Assess left atrial size, left ventricular systolic and diastolic function, and exclude structural heart disease or infiltrative disorders

Standard Inpatient Orders (100% Generic INN)

  • ✓Diet/Activity: Fall precautions, bed rest with continuous cardiac telemetry, avoid vagal maneuvers
  • ✓Monitoring: Continuous ECG telemetry, noninvasive BP every 15-30 minutes, continuous pulse oximetry, transcutaneous pacing pads on standby
  • ✓IV Hydration: 0.9% Normal Saline at 50-75 mL/hr maintenance
  • ✓Pharmacotherapy (Generic Only): ACUTE HEMODYNAMICALLY UNSTABLE BRADYCARDIA / PAUSE: Atropine 1 mg IV bolus (cautious, may trigger tachyarrhythmia); Epinephrine 2-10 mcg/min IV infusion OR Dopamine 5-10 mcg/kg/min IV infusion; Transcutaneous or temporary transvenous cardiac pacing for symptomatic prolonged pauses (> 3 seconds) or hemodynamic instability; MEDICATION ADJUSTMENT: Immediately discontinue or reduce all AV nodal / sinus node suppressing drugs (beta-blockers, non-dihydropyridine CCBs, digoxin, antiarrhythmics); DEFINITIVE MANAGEMENT: Dual-chamber Permanent Pacemaker (DDDR) implantation to prevent bradycardic arrest, which then safely allows pharmacologic beta-blocker or antiarrhythmic therapy for the tachycardia component; ANTICOAGULATION: Oral anticoagulation (Apixaban 5 mg twice daily or Rivaroxaban 20 mg daily) based on CHA2DS2-VASc score for thromboembolism prophylaxis

Red Flags & Clinical Pitfalls

  • !Administering high-dose beta-blockers or calcium channel blockers to treat the tachycardia phase without a pacemaker in place (triggers catastrophic asystolic arrest during subsequent bradycardic pauses)
  • !Prolonged sinus arrest > 3-5 seconds causing syncope, fall with intracranial hemorrhage, or sudden death
  • !High risk of thromboembolic stroke upon spontaneous conversion of prolonged paroxysmal AF to sinus rhythm without adequate anticoagulation

Acute Prosthetic Valve Thrombosis

ICD-10: T82.858ASource: Braunwald's Heart Disease - Ch. 71

History & Clinical Examination Pearls

  • •Clinical presentation: Sudden or rapidly progressive dyspnea, orthopnea, acute pulmonary edema, cardiogenic shock, or sudden embolic events (stroke, acute limb ischemia) in a patient with a mechanical or bioprosthetic valve
  • •Anticoagulation compliance history: History of subtherapeutic INR (< 2.0-2.5 for aortic, < 2.5-3.5 for mitral), temporary interruption of Warfarin for invasive procedures without adequate heparin bridging, or non-compliance
  • •Position and valve type: Much higher incidence in mechanical valves than bioprosthetic; mitral and tricuspid mechanical valves carry 2 to 3 times higher thrombosis risk than aortic mechanical valves
  • •Auscultation of prosthetic valve sounds: Muffled, diminished, or complete absence of the normal crisp mechanical clicking sounds (loss of prosthetic closing click); new regurgitant or obstructive murmur across the prosthetic valve
  • •Hemodynamic status: Profound hypotension, resting tachycardia, narrow pulse pressure, cool clammy extremities indicating low cardiac output / cardiogenic shock
  • •Pulmonary and venous signs: Florid pulmonary rales, acute jugular venous distension, cyanosis

Diagnostic Tests & Paraclinics

  • •Transthoracic & Transesophageal Echocardiography: TEE is the gold standard: directly visualizes thrombus / pannus on valve occluder or sewing ring; restricted or absent leaflet/disc motion; markedly elevated transvalvular mean pressure gradient (e.g. mitral mean gradient > 8-10 mmHg, aortic mean gradient > 35-45 mmHg); severely reduced effective orifice area; new pathological regurgitant jet
  • •Cinefluoroscopy: Rapid bedside assessment of mechanical valve leaflet mobility: reveals restricted opening or closing angles of the radiopaque tilting discs or bileaflet occluders
  • •Coagulation and Biomarkers: Urgent international normalized ratio (INR; typically subtherapeutic < 2.0), elevated cardiac troponin, high BNP/NT-proBNP, leukocytosis

Standard Inpatient Orders (100% Generic INN)

  • ✓Diet/Activity: Strict NPO, intensive care unit admission, bed rest with continuous cardiac telemetry
  • ✓Monitoring: Continuous arterial line for beat-to-beat BP, continuous ECG telemetry, Foley catheter for strict urine output
  • ✓IV Hydration: Cautious fluid management; avoid volume overload
  • ✓Pharmacotherapy (Generic Only): UNFRACTIONATED HEPARIN: Unfractionated Heparin IV bolus 80 U/kg followed by continuous infusion 18 U/kg/hr (target aPTT 70-100 seconds); DEFINITIVE INTERVENTIONS (STRATIFIED BY STATUS AND THROMBUS SIZE): 1) CRITICALLY ILL / NYHA CLASS III-IV / SHOCK / OBSTRUCTIVE THROMBUS: Emergent cardiac surgery for valve replacement/thrombectomy OR Low-Dose Slow-Infusion Fibrinolytic Therapy: Alteplase (tPA) 25 mg IV infused slowly over 6 hours without bolus (repeat up to 4 times if gradient remains elevated; success rate > 90% with low bleeding risk); 2) NON-OBSTRUCTIVE SMALL THROMBUS (< 5 mm): Intravenous Unfractionated Heparin optimization and restart Warfarin (target INR 3.0-4.0); AVOID EXCESSIVE VASOPRESSORS: Restore forward flow via thrombolysis or surgery

Red Flags & Clinical Pitfalls

  • !Rapid systemic embolic stroke or mesenteric infarction caused by clot fragmentation during thrombolysis or manipulation
  • !Acute total prosthetic valve obstruction causing instantaneous circulatory collapse and electromechanical dissociation
  • !Intracranial hemorrhage during systemic fibrinolysis (requires immediate neurosurgical evaluation and reversal with Protamine Sulfate and prothrombin complex concentrate)

Acute Right Ventricular Myocardial Infarction

ICD-10: I21.A1Source: Braunwald's Heart Disease - Ch. 58

History & Clinical Examination Pearls

  • •Clinical presentation: Acute retrosternal chest pain or epigastric discomfort accompanied by profound weakness, nausea, vomiting, hiccupping, and diaphoresis
  • •Precipitating disaster: Sudden catastrophic, precipitous drop in blood pressure and syncope immediately following administration of sublingual or intravenous Nitroglycerin or Morphine
  • •Culprit anatomy: Occurs in 30-50% of acute inferior myocardial infarctions due to proximal occlusion of the Right Coronary Artery (RCA) upstream of the acute marginal branches
  • •Classic Diagnostic Triad: 1) Systemic arterial hypotension, 2) Elevated jugular venous pressure with distended neck veins, 3) Clear lung fields on pulmonary auscultation (absence of rales/crackles)
  • •Kussmaul's Sign: Pathognomonic inspiratory rise (or lack of normal inspiratory fall) in jugular venous pressure, reflecting non-compliant, stiff right ventricle unable to accommodate inspiratory venous return
  • •Arrhythmias and conduction: Bradycardia, advanced AV block (first-degree, Mobitz II, or complete third-degree AV block) due to ischemia of the AV nodal artery (branch of distal RCA)

Diagnostic Tests & Paraclinics

  • •Right-Sided 12-Lead Electrocardiogram: Mandatory in all inferior STEMIs (leads II, III, aVF): ST-segment elevation >= 0.5-1.0 mm in lead V4R (and V3R) has > 90% sensitivity and specificity for acute RV infarction; ST elevation in lead III greater than lead II; ST elevation in V1 greater than V2
  • •Echocardiography: Right ventricular free-wall hypokinesis or akinesis; RV dilation with RV/LV ratio > 1; paradoxical interventricular septal motion toward the LV during diastole; elevated tricuspid regurgitant jet velocity
  • •Hemodynamics (Right Heart Catheterization): Disproportionately elevated right atrial pressure (RAP > 10 mmHg) and elevated RAP/PCWP ratio > 0.8; low or normal pulmonary capillary wedge pressure (PCWP)

Standard Inpatient Orders (100% Generic INN)

  • ✓Diet/Activity: Strict NPO, flat supine position (Trendelenburg position if severely hypotensive to augment venous return), continuous telemetry
  • ✓Monitoring: Continuous arterial line for blood pressure, continuous 12-lead ECG telemetry (V4R lead), central venous catheter, Foley catheter
  • ✓IV Hydration: AGGRESSIVE INTRAVENOUS PRELOAD OPTIMIZATION: 0.9% Normal Saline 500-1000 mL IV bolus rapidly over 15-30 minutes, repeated up to 1-2 liters to achieve optimal RV filling pressures (target CVP 12-15 mmHg) and drive forward flow across pulmonary bed
  • ✓Pharmacotherapy (Generic Only): ABSOLUTELY CONTRAINDICATED DRUGS: Nitroglycerin, Morphine, Diuretics (Furosemide), ACE inhibitors, and Beta-blockers MUST BE STRICTLY AVOIDED (venodilators and diuretics abolish preload, triggering fatal cardiovascular collapse!); VASOPRESSOR / INOTROPE: If MAP remains < 65 mmHg despite 1-2 L saline loading: initiate Norepinephrine 0.05-0.2 mcg/kg/min (restores systemic perfusion pressure) PLUS Dobutamine continuous IV infusion 2.5-10 mcg/kg/min (augments RV contractility); BRADYARRHYTHMIA MANAGEMENT: Atropine 1 mg IV for symptomatic bradycardia; temporary transvenous pacing for high-grade AV block; EMERGENCY REPERFUSION: Immediate emergency primary Percutaneous Coronary Intervention (PCI) of proximal RCA to salvage RV myocardium

Red Flags & Clinical Pitfalls

  • !Administering Nitroglycerin or Morphine to a patient with inferior STEMI and RV involvement (causes instantaneous precipitous circulatory collapse)
  • !Administering Furosemide or other loop diuretics (wipes out preload and induces profound uncorrectable shock)
  • !Severe bradycardia or complete AV block with loss of AV synchrony causing catastrophic reduction in cardiac output

Hypertensive Emergency with Acute Encephalopathy

ICD-10: I16.1Source: Braunwald's Heart Disease - Ch. 46

History & Clinical Examination Pearls

  • •Clinical presentation: Acute onset severe, generalized, throbbing headache accompanied by confusion, lethargy, cognitive clouding, visual disturbances (blurring, scotoma, cortical blindness), nausea, vomiting, and seizures
  • •Blood pressure severity: Severe acute elevation of blood pressure, typically systolic BP > 180-220 mmHg and/or diastolic BP > 120-140 mmHg
  • •Precipitating causes: Sudden cessation of antihypertensive medications (especially clonidine or beta-blocker rebound), acute renovascular disease, acute glomerulonephritis, scleroderma renal crisis, pheochromocytoma, preeclampsia, or cocaine/amphetamine toxicity
  • •Neurological examination: Altered mental status, fluctuating confusion, delirium, stupor, hyperreflexia, extensor plantar responses (Babinski sign), focal neurological deficits that are characteristically non-anatomic and transient
  • •Fundoscopic examination: Bilateral advanced hypertensive retinopathy: Grade IV changes with bilateral Papilledema (blurring of optic disc margins), flame-shaped retinal hemorrhages, cotton-wool spots, and macular exudates
  • •Cardiovascular exam: Forceful apical impulse, S4 gallop, signs of concomitant acute heart failure or pulmonary rales

Diagnostic Tests & Paraclinics

  • •Neuroimaging (Brain MRI/CT): Brain MRI is the definitive imaging modality: demonstrates Posterior Reversible Encephalopathy Syndrome (PRES) with bilateral, symmetric hyperintensities on T2/FLAIR predominantly involving white matter of the parieto-occipital lobes (vasogenic cerebral edema); non-contrast Head CT rules out acute intracranial hemorrhage
  • •Laboratory Evaluation: Complete metabolic panel: elevated serum creatinine and BUN (acute kidney injury); Complete blood count with peripheral smear: schistocytes, thrombocytopenia (microangiopathic hemolytic anemia / thrombotic microangiopathy); Urinalysis: proteinuria, hematuria, red cell casts
  • •12-Lead Electrocardiogram & CXR: Left ventricular hypertrophy, acute ST-T wave changes; chest radiograph showing cardiomegaly or pulmonary vascular congestion

Standard Inpatient Orders (100% Generic INN)

  • ✓Diet/Activity: Strict NPO, quiet dark room in ICU, seizure precautions, bed rest with head of bed elevated 30 degrees
  • ✓Monitoring: Continuous intra-arterial line blood pressure monitoring mandatory, continuous neurological checks (GCS every 30-60 min), continuous ECG telemetry, Foley catheter for strict hourly urine output
  • ✓IV Hydration: 0.9% Normal Saline at 50 mL/hr KVO; avoid dehydration and avoid fluid overload
  • ✓Pharmacotherapy (Generic Only): BLOOD PRESSURE REDUCTION TARGET: Reduce Mean Arterial Pressure (MAP) by NO MORE THAN 20-25% in the first hour; then gradually reduce blood pressure to 160/100 mmHg over the subsequent 2-6 hours; (CRITICAL: Precipitous normalization of BP causes cerebral, coronary, and renal hypoperfusion and ischemic stroke!); FIRST-LINE INTRAVENOUS ANTIHYPERTENSIVES: Nicardipine continuous IV infusion starting at 5 mg/hr, titrated by 2.5 mg/hr every 15 minutes to max 15 mg/hr OR Clevidipine 1-2 mg/hr IV infusion titrated up to 16-32 mg/hr OR Labetalol 20 mg IV bolus over 2 minutes, followed by 40-80 mg every 10 minutes (max 300 mg) or continuous infusion at 0.5-2.0 mg/min; ALTERNATIVE / SECOND-LINE: Sodium Nitroprusside 0.3-2.0 mcg/kg/min IV infusion (caution: risk of thiocyanate/cyanide toxicity with prolonged infusion or renal impairment); SEIZURE CONTROL: Lorazepam 2-4 mg IV bolus

Red Flags & Clinical Pitfalls

  • !Overly rapid or excessive blood pressure reduction (> 25% drop in MAP), which shifts below the autoregulatory threshold of the brain and precipitates massive cerebral infarction or acute blindness
  • !Administering short-acting sublingual nifedipine (causes unpredictable precipitous hypotension, reflex tachycardia, stroke, and myocardial infarction; strictly contraindicated!)
  • !Status epilepticus or intracranial herniation due to progressive malignant cerebral edema

Subacute and Transient Constrictive Pericarditis

ICD-10: I31.1Source: Braunwald's Heart Disease - Ch. 83

History & Clinical Examination Pearls

  • •Clinical presentation: Progressive signs of severe systemic venous congestion: rapid abdominal swelling (ascites), early satiety, postprandial fullness, bilateral leg edema, and exertional dyspnea out of proportion to pulmonary findings
  • •Etiological triggers: Prior acute viral or idiopathic pericarditis, previous cardiac surgery (post-pericardiotomy syndrome), mediastinal radiation therapy, tuberculosis, or connective tissue disease
  • •Transient / Subacute form: Recognition that a significant subset (approx 10-20%) of post-pericarditis constriction is transient and reversible with aggressive medical anti-inflammatory therapy, avoiding premature pericardiectomy
  • •Jugular Venous Pulse (Diagnostic Benchmark): Markedly elevated JVP with prominent, steep, rapid 'y' descent (Friedreich's sign: rapid ventricular filling in early diastole) and steep 'x' descent; Kussmaul's Sign: lack of inspiratory fall or paradoxical inspiratory rise in jugular venous pressure
  • •Cardiac Auscultation: Pericardial Knock: High-pitched, early diastolic sound heard 0.08 to 0.12 seconds after S2 at the apex/left sternal border (caused by sudden abrupt cessation of ventricular diastolic filling by the rigid pericardium; earlier than S3)
  • •Systemic venous signs: Marked ascites disproportionate to peripheral edema ('ascites precox'), tender hepatomegaly with prominent hepatojugular reflux, spider angiomas (pseudo-cirrhosis)

Diagnostic Tests & Paraclinics

  • •Echocardiography (Mayo Diagnostic Criteria): 1) Marked respiratory variation (> 25%) in mitral E-velocity and reciprocal change (> 40%) in tricuspid E-velocity; 2) Annulus Reversus: Mitral medial mitral annular tissue Doppler e' velocity is higher than lateral annular e' velocity (medial e' >= 9 cm/s; opposite of normal/myocardial disease); 3) Ventricular septal shift / shudder with inspiration ('septal bounce'); 4) Prominent diastolic flow reversal in hepatic veins on expiration
  • •Cardiac CT / MRI: Direct visualization of thickened (> 3-4 mm), fibrotic, or calcified pericardial layers; pericardial late gadolinium enhancement (LGE) on MRI indicates active ongoing pericardial inflammation (strongly predicts potential reversibility of constriction with medical therapy!)
  • •Invasive Cardiac Catheterization: Simultaneous right and left ventricular pressure tracings: 'Dip-and-plateau' or 'Square root sign' in early diastolic ventricular pressures; ventricular interdependence: dynamic respiratory discordance between peak systolic LV and RV pressures

Standard Inpatient Orders (100% Generic INN)

  • ✓Diet/Activity: Strict low-sodium diet (< 2 g/day), fluid restriction (1-1.5 L/day), bed rest with cardiac monitoring during acute instability
  • ✓Monitoring: Daily weights at 06:00, strict intake and output, continuous telemetry, noninvasive blood pressure monitoring
  • ✓IV Hydration: STRICT FLUID RESTRICTION; avoid fluid boluses
  • ✓Pharmacotherapy (Generic Only): FIRST-LINE MEDICAL TRIAL FOR TRANSIENT/SUBACUTE CONSTRICTION: Full-dose Anti-Inflammatory Therapy: Ibuprofen 600-800 mg orally every 8 hours (or Aspirin 750-1000 mg every 8 hours) for 2-4 weeks with gradual taper PLUS Colchicine 0.5 mg orally twice daily (0.5 mg daily if < 70 kg) for 3-6 months; CORTICOSTEROID ADJUNCT: If persistent inflammation or refractory symptoms: Prednisone 0.5-1.0 mg/kg/day orally with gradual slow taper; DECONGESTIVE DIURESIS: Furosemide 40-80 mg IV bolus plus Spironolactone 25-50 mg orally daily (cautious titration to relieve ascites and edema without dropping cardiac output); DEFINITIVE SURGICAL THERAPY: Pericardiectomy (complete surgical stripping of the pericardium) indicated for chronic, irreversible constriction without active inflammation (calcified, LGE-negative)

Red Flags & Clinical Pitfalls

  • !Over-diuresis causing profound drop in cardiac output and prerenal azotemia (rigid pericardium requires adequate filling pressure to maintain stroke volume)
  • !Performing premature irreversible surgical pericardiectomy in transient inflammatory constriction that could resolve completely with medical therapy
  • !Misdiagnosing constrictive pericarditis as primary cryptogenic liver cirrhosis, leading to inappropriate liver biopsy and delayed cardiac treatment